Free Access
The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate
Abstract
- 1
The interaction of two dissociative anaesthetics, ketamine and phencyclidine, with the responses of spinal neurones to the electrophoretic administration of amino acids and acetylcholine was studied in decerebrate or pentobarbitone‐anaesthetized cats and rats.
- 2
Both ketamine and phencyclidine selectively blocked excitation by N‐methyl‐aspartate (NMA) with little effect on excitation by quisqualate and kainate.
- 3
Ketamine reduced responses to L‐aspartate somewhat more than those of l‐glutamate; the sensitivity of responses to these two putative transmitters was between that to NMA on one hand and that to quisqualate or kainate on the other.
- 4
On Renshaw cells, ketamine and phencyclidine reduced responses to acetylcholine less than those to NMA but more than those to quisqualate or kainate. Dorsal root‐evoked synaptic excitation of Renshaw cells was reduced to a greater extent than that following ventral root excitation.
- 5
Intravenous ketamine, 2.5–20 mg/kg, and phencyclidine, 0.2–0.5 mg/kg, also selectively blocked excitation of neurones by NMA.
- 6
Ketamine showed no consistent or selective effect on inhibition of spinal neurones by electrophoretically administered glycine or γ‐aminobutyricacid (GABA).
- 7
The results suggest that reduction of synaptic excitation mediated via NMA receptors contributes to the anaesthetic/analgesic properties of these two dissociative anaesthetics.
Citing Literature
Number of times cited: 771
- Shoi Shi and Hiroki R. Ueda, Ca2+‐Dependent Hyperpolarization Pathways in Sleep Homeostasis and Mental Disorders, BioEssays, 40, 1, (2017).
- Vitor Silva Pereira and Vinícius Antonio Hiroaki-Sato, A brief history of antidepressant drug development: from tricyclics to beyond ketamine, Acta Neuropsychiatrica, (1), (2018).
- Michael George Zaki Ghali, Role of the medullary lateral tegmental field in sympathetic control, Journal of Integrative Neuroscience, 16, 2, (189), (2018).
- Maiko Kusano, Kei Zaitsu, Kentaro Taki, Kazuaki Hisatsune, Jun'ichi Nakajima, Takako Moriyasu, Tomomi Asano, Yumi Hayashi, Hitoshi Tsuchihashi and Akira Ishii, Fatal intoxication by 5F–ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q‐TOFMS, Drug Testing and Analysis, 10, 2, (284-293), (2017).
- Joseph T. Coyle and Darrick T. Balu, The Role of Serine Racemase in the Pathophysiology of Brain Disorders, Apprentices to Genius: A tribute to Solomon H. Snyder, 10.1016/bs.apha.2017.10.002, (35-56), (2018).
- Riccardo Avvisati, Maria Meringolo, Emiliana Stendardo, Elisa Malavasi, Silvia Marinelli and Aldo Badiani, Intravenous self‐administration of benzydamine, a non‐steroidal anti‐inflammatory drug with a central cannabinoidergic mechanism of action, Addiction Biology, 23, 2, (610-619), (2017).
- Fay A. Guarraci, Chantal M.F. Gonzalez, Devon Lucero, Paige D. Womble, Heba Abdel-Rahim, Jennie DeVore, Marcela Nicole Kunkel, Emma Quadlander, Morgan Stinnett and Jessica Boyette-Davis, The effects of ketamine on sexual behavior, anxiety, and locomotion in female rats, Pharmacology Biochemistry and Behavior, 165, (36), (2018).
- Georges Mion, Histoire de la kétamine et du psychédélisme, Annales Médico-psychologiques, revue psychiatrique, 10.1016/j.amp.2017.07.002, 175, 7, (661-664), (2017).
- Hongqiu Guo, L. Miguel Camargo, Fred Yeboah, Mary Ellen Digan, Honglin Niu, Yue Pan, Stephan Reiling, Gilberto Soler-Llavina, Wilhelm A. Weihofen, Hao-Ran Wang, Y. Gopi Shanker, Travis Stams and Anke Bill, A NMDA-receptor calcium influx assay sensitive to stimulation by glutamate and glycine/D-serine, Scientific Reports, 7, 1, (2017).
- Dian-Shi Wang, Antonello Penna and Beverley A. Orser, Ketamine Increases the Function of γ-Aminobutyric Acid Type A Receptors in Hippocampal and Cortical Neurons, Anesthesiology, 126, 4, (666), (2017).
- Jahanshah Amin and Meena S. Subbarayan, Orthosteric- versus allosteric-dependent activation of the GABAA receptor requires numerically distinct subunit level rearrangements, Scientific Reports, 7, 1, (2017).
- Sanders A. McDougall, Andrea E. Moran, Timothy J. Baum, Matthew G. Apodaca and Vanessa Real, Effects of ketamine on the unconditioned and conditioned locomotor activity of preadolescent and adolescent rats: impact of age, sex, and drug dose, Psychopharmacology, 234, 18, (2683), (2017).
- Stephen Thornton, David Lisbon, Thomas Lin and Roy Gerona, Beyond Ketamine and Phencyclidine: Analytically Confirmed Use of Multiple Novel Arylcyclohexylamines, Journal of Psychoactive Drugs, 49, 4, (289), (2017).
- Maged M. Harraz and Solomon H. Snyder, Antidepressant Actions of Ketamine Mediated by the Mechanistic Target of Rapamycin, Nitric Oxide, and Rheb, Neurotherapeutics, 10.1007/s13311-017-0540-0, 14, 3, (728-733), (2017).
- Raphaël Millière, Looking for the Self: Phenomenology, Neurophysiology and Philosophical Significance of Drug-induced Ego Dissolution, Frontiers in Human Neuroscience, 11, (2017).
- Natalia Malikowska, Kinga Sałat and Adrian Podkowa, Comparison of pro-amnesic efficacy of scopolamine, biperiden, and phencyclidine by using passive avoidance task in CD-1 mice, Journal of Pharmacological and Toxicological Methods, 86, (76), (2017).
- Viviane S. Hambrecht-Wiedbusch, Duan Li and George A. Mashour, Paradoxical Emergence, Anesthesiology, 126, 3, (482), (2017).
- Kenji Hashimoto, Rapid Antidepressant Activity of Ketamine Beyond NMDA Receptor, The NMDA Receptors, 10.1007/978-3-319-49795-2_4, (69-81), (2017).
- Marshall W. Tyler, Harmony B. Yourish, Dawn F. Ionescu and Stephen J. Haggarty, Classics in Chemical Neuroscience: Ketamine, ACS Chemical Neuroscience, 10.1021/acschemneuro.7b00074, 8, 6, (1122-1134), (2017).
- Anna Johansson, Daniel Lindstedt, Markus Roman, Gunilla Thelander, Elisabet I. Nielsen, Ulrica Lennborn, Håkan Sandler, Sten Rubertsson, Johan Ahlner, Robert Kronstrand and Fredrik C. Kugelberg, A non-fatal intoxication and seven deaths involving the dissociative drug 3-MeO-PCP, Forensic Science International, 275, (76), (2017).
- Shigeto Maekawa, Kota Sato, Kosuke Fujita, Reiko Daigaku, Hiroshi Tawarayama, Namie Murayama, Satoru Moritoh, Takeshi Yabana, Yukihiro Shiga, Kazuko Omodaka, Kazuichi Maruyama, Koji M. Nishiguchi and Toru Nakazawa, The neuroprotective effect of hesperidin in NMDA-induced retinal injury acts by suppressing oxidative stress and excessive calpain activation, Scientific Reports, 10.1038/s41598-017-06969-4, 7, 1, (2017).
- Wendy M. Campana, Elisabetta Mantuano, Pardis Azmoon, Kenneth Henry, Michael A. Banki, John H. Kim, Donald P. Pizzo and Steven L. Gonias, Ionotropic glutamate receptors activate cell signaling in response to glutamate in Schwann cells, The FASEB Journal, 31, 4, (1744), (2017).
- Graham L. Collingridge, Yeseul Lee, Zuner A. Bortolotto, Heather Kang and David Lodge, Antidepressant Actions of Ketamine Versus Hydroxynorketamine, Biological Psychiatry, 81, 8, (e65), (2017).
- James H. Ho and Paul I. Dargan, Arylcyclohexamines: Ketamine, Phencyclidine, and Analogues, Critical Care Toxicology, 10.1007/978-3-319-17900-1_124, (1439-1484), (2017).
- Y.N. Dong, H. Lin, A. Rattelle, J. Panzer and D.R. Lynch, Excitotoxicity ☆, Reference Module in Biomedical Sciences, 10.1016/B978-0-12-801238-3.65836-1, (2017).
- Heather Kang, Pojeong Park, Zuner A. Bortolotto, Simon D. Brandt, Tristan Colestock, Jason Wallach, Graham L. Collingridge and David Lodge, Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties, Neuropharmacology, 10.1016/j.neuropharm.2016.08.004, 112, (144-149), (2017).
- James Maksymetz, Sean P. Moran and P. Jeffrey Conn, Targeting metabotropic glutamate receptors for novel treatments of schizophrenia, Molecular Brain, 10, 1, (2017).
- Elizabeth A. K. Phillips, Christoph E. Schreiner and Andrea R. Hasenstaub, Diverse effects of stimulus history in waking mouse auditory cortex, Journal of Neurophysiology, 118, 2, (1376), (2017).
- Greta Kasputytė and Aurika Karbonskienė, KETAMINAS POOPERACINIAM SKAUSMUI GYDYTI, Sveikatos mokslai, 27, 3, (64), (2017).
- Georges Mion, History of anaesthesia, European Journal of Anaesthesiology, 10.1097/EJA.0000000000000638, 34, 9, (571-575), (2017).
- Maryam Farahmandfar, Ardeshir Akbarabadi, Atefeh Bakhtazad and Mohammad-Reza Zarrindast, Recovery from ketamine-induced amnesia by blockade of GABA-A receptor in the medial prefrontal cortex of mice, Neuroscience, 344, (48), (2017).
- Phillip E. Vlisides, Tarik Bel-Bahar, UnCheol Lee, Duan Li, Hyoungkyu Kim, Ellen Janke, Vijay Tarnal, Adrian B. Pichurko, Amy M. McKinney, Bryan S. Kunkler, Paul Picton and George A. Mashour, Neurophysiologic Correlates of Ketamine Sedation and Anesthesia, Anesthesiology, 127, 1, (58), (2017).
- Abigail E. Cline and Jake E. Turrentine, Compounded Topical Analgesics for Chronic Pain, Dermatitis, 27, 5, (263), (2016).
- James H. Ho and Paul I. Dargan, Arylcyclohexamines (Ketamine, Phencyclidine, and Analogues), Critical Care Toxicology, 10.1007/978-3-319-20790-2_124-1, (1-46), (2016).
- Weili Zhu, Zengbo Ding, Yinan Zhang, Jie Shi, Kenji Hashimoto and Lin Lu, Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant, Neuroscience Bulletin, 32, 6, (557), (2016).
- M. Steffens, B. Becker, C. Neumann, A.M. Kasparbauer, I. Meyhöfer, B. Weber, M.A. Mehta, R. Hurlemann and U. Ettinger, Effects of ketamine on brain function during smooth pursuit eye movements, Human Brain Mapping, 37, 11, (4047-4060), (2016).
- Patricia T. Michie, Manuel S. Malmierca, Lauren Harms and Juanita Todd, The neurobiology of MMN and implications for schizophrenia, Biological Psychology, 116, (90), (2016).
- Roberto Malinow, Ketamine steps out of the darkness, Nature, 533, 7604, (477), (2016).
- Linda C.J. Oudejans, Monique van Velzen and Albert Dahan, Ketamine Analgesia, Neuropathology of Drug Addictions and Substance Misuse, 10.1016/B978-0-12-800212-4.00050-9, (541-550), (2016).
- Giles E. Hardingham and Kim Q. Do, Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis, Nature Reviews Neuroscience, 17, 2, (125), (2016).
- Maryam Farahmandfar, Atefeh Bakhtazad, Ardeshir Akbarabadi and Mohammad-Reza Zarrindast, The influence of dopaminergic system in medial prefrontal cortex on ketamine-induced amnesia in passive avoidance task in mice, European Journal of Pharmacology, 10.1016/j.ejphar.2016.03.060, 781, (45-52), (2016).
- Joseph T. Coyle, d-Serine and the Pathophysiology of Schizophrenia, D-Amino Acids, 10.1007/978-4-431-56077-7_7, (101-118), (2016).
- Lewis A. Opler, Mark G. A. Opler and Amy F. T. Arnsten, Ameliorating treatment-refractory depression with intranasal ketamine: potential NMDA receptor actions in the pain circuitry representing mental anguish, CNS Spectrums, 21, 01, (12), (2016).
- Marko A. Peltoniemi, Nora M. Hagelberg, Klaus T. Olkkola and Teijo I. Saari, Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy, Clinical Pharmacokinetics, 10.1007/s40262-016-0383-6, 55, 9, (1059-1077), (2016).
- Ana Pocivavsek, Francesca M. Notarangelo, Hui-Qiu Wu, John P. Bruno and Robert Schwarcz, Astrocytes as Pharmacological Targets in the Treatment of Schizophrenia, Modeling the Psychopathological Dimensions of Schizophrenia - From Molecules to Behavior, 10.1016/B978-0-12-800981-9.00025-0, (423-443), (2016).
- Hui Zhang, Xiao-ru Sun, Jing Wang, Zhen-zhen Zhang, Hong-ting Zhao, Hui-hui Li, Mu-huo Ji, Kuan-yu Li and Jian-jun Yang, Reactive Oxygen Species-mediated Loss of Phenotype of Parvalbumin Interneurons Contributes to Long-term Cognitive Impairments After Repeated Neonatal Ketamine Exposures, Neurotoxicity Research, 30, 4, (593), (2016).
- Toru Nishikawa, d-Serine Signaling and Schizophrenia, D-Amino Acids, 10.1007/978-4-431-56077-7_6, (81-99), (2016).
- Jason Wallach, Heather Kang, Tristan Colestock, Hamilton Morris, Zuner A. Bortolotto, Graham L. Collingridge, David Lodge, Adam L. Halberstadt, Simon D. Brandt, Adeboye Adejare and Joohyung Lee, Pharmacological Investigations of the Dissociative ‘Legal Highs’ Diphenidine, Methoxphenidine and Analogues, PLOS ONE, 11, 6, (e0157021), (2016).
- Runtao Ding, Yanning Li, Ao Du, Hao Yu, Bolin He, Ruipeng Shen, Jichuan Zhou, Lu Li, Wen Cui, Guohua Zhang, Yan Lu and Xu Wu, Changes in hippocampal AMPA receptors and cognitive impairments in chronic ketamine addiction models: another understanding of ketamine CNS toxicity, Scientific Reports, 6, 1, (2016).
- Simon C. Baker, Saqib Shabir, Nikolaos T. Georgopoulos and Jennifer Southgate, Ketamine-Induced Apoptosis in Normal Human Urothelial Cells, The American Journal of Pathology, 186, 5, (1267), (2016).
- Tadahiro Katayama, Yoshiaki Suzuki and Eiichi Jodo, Psychosis Induced by Phencyclidine (Also Called PCP or Angel Dust), Neuropathology of Drug Addictions and Substance Misuse, 10.1016/B978-0-12-800212-4.00065-0, (703-713), (2016).
- Ryan Gallagher, Jonathan Dangers and Stephen L. Thornton, Do trauma patients with phencyclidine-positive urine drug screens have increased morbidity or mortality?, The American Journal of Emergency Medicine, 34, 6, (1066), (2016).
- Viviana Filpa, Elisabetta Moro, Marina Protasoni, Francesca Crema, Gianmario Frigo and Cristina Giaroni, Role of glutamatergic neurotransmission in the enteric nervous system and brain-gut axis in health and disease, Neuropharmacology, 10.1016/j.neuropharm.2016.08.024, 111, (14-33), (2016).
- Matthew Volgraf, Benjamin D. Sellers, Yu Jiang, Guosheng Wu, Cuong Q. Ly, Elisia Villemure, Richard M. Pastor, Po-wai Yuen, Aijun Lu, Xifeng Luo, Mingcui Liu, Shun Zhang, Liang Sun, Yuhong Fu, Patrick J. Lupardus, Heidi J.A. Wallweber, Bianca M. Liederer, Gauri Deshmukh, Emile Plise, Suzanne Tay, Paul Reynen, James Herrington, Amy Gustafson, Yichin Liu, Akim Dirksen, Matthias G. A. Dietz, Yanzhou Liu, Tzu-Ming Wang, Jesse E. Hanson, David Hackos, Kimberly Scearce-Levie and Jacob B. Schwarz, Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design, Journal of Medicinal Chemistry, 59, 6, (2760), (2016).
- Eiichi Jodo, Phencyclidine (Also Called Angel Dust or PCP) and the Firing Activity of Neurons, Neuropathology of Drug Addictions and Substance Misuse, 10.1016/B978-0-12-800212-4.00055-8, (593-603), (2016).
- Matthew Sykes, Natalie A. Matheson, Philip W. Brownjohn, Alexander D. Tang, Jennifer Rodger, Jonathan B. H. Shemmell and John N. J. Reynolds, Differences in Motor Evoked Potentials Induced in Rats by Transcranial Magnetic Stimulation under Two Separate Anesthetics: Implications for Plasticity Studies, Frontiers in Neural Circuits, 10, (2016).
- Iveta Vojtechova, Tomas Petrasek, Hana Hatalova, Adela Pistikova, Karel Vales and Ales Stuchlik, Dizocilpine (MK-801) impairs learning in the active place avoidance task but has no effect on the performance during task/context alternation, Behavioural Brain Research, 305, (247), (2016).
- Frank Anthony Myers, Martin H. Bluth and Wellman W. Cheung, Ketamine, Clinics in Laboratory Medicine, 36, 4, (721), (2016).
- Benneth Ben-Azu, Itivere Adrian Omogbiya, Adegbuyi Oladele Aderibigbe, Solomon Umukoro, Abayomi Mayowa Ajayi, Aya-Ebi Okubo Eneni and Ezekiel O. Iwalewa, Doxycycline Ameliorates Schizophrenia-Like Behaviors in Experimental Models in Mice by Targeting Underlying Oxidative Stress, Journal of Behavioral and Brain Science, 06, 13, (539), (2016).
- Richard J. Traystman, Effect of Anesthesia in Stroke Models, Rodent Models of Stroke, 10.1007/978-1-4939-5620-3_10, (123-146), (2016).
- Miranda L. Fisher, Anu Loukola, Jaakko Kaprio and Jill R. Turner, Role of the Neuregulin Signaling Pathway in Nicotine Dependence and Co-morbid Disorders, Nicotine Use in Mental Illness and Neurological Disorders, 10.1016/bs.irn.2015.07.006, (113-131), (2015).
- Anders Helander, Olof Beck and Matilda Bäckberg, Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine, Clinical Toxicology, 10.3109/15563650.2015.1033630, 53, 5, (446-453), (2015).
- Julie Jouguelet‐Lacoste, Luca La Colla, Dennis Schilling and Jacques E. Chelly, The Use of Intravenous Infusion or Single Dose of Low‐Dose Ketamine for Postoperative Analgesia: A Review of the Current Literature, Pain Medicine, 16, 2, (383-403), (2014).
- D Lodge and M S Mercier, Ketamine and phencyclidine: the good, the bad and the unexpected, British Journal of Pharmacology, 172, 17, (4254-4276), (2015).
- Jason Wallach, Pierce V. Kavanagh, Gavin McLaughlin, Noreen Morris, John D. Power, Simon P. Elliott, Marion S. Mercier, David Lodge, Hamilton Morris, Nicola M. Dempster and Simon D. Brandt, Preparation and characterization of the ‘research chemical’ diphenidine, its pyrrolidine analogue, and their 2,2‐diphenylethyl isomers, Drug Testing and Analysis, 7, 5, (358-367), (2014).
- James L. Wallis, Mark W. Irvine, David E. Jane, David Lodge, Graham L. Collingridge and Zuner A. Bortolotto, An interchangeable role for kainate and metabotropic glutamate receptors in the induction of rat hippocampal mossy fiber long‐term potentiation in vivo, Hippocampus, 25, 11, (1407-1417), (2015).
- Claudia Dacquino, Pietro De Rossi and Gianfranco Spalletta, Schizophrenia and bipolar disorder: The road from similarities and clinical heterogeneity to neurobiological types, Clinica Chimica Acta, 449, (49), (2015).
- D. Pal, V.S. Hambrecht-Wiedbusch, B.H. Silverstein and G.A. Mashour, Electroencephalographic coherence and cortical acetylcholine during ketamine-induced unconsciousness, British Journal of Anaesthesia, 114, 6, (979), (2015).
- Arun Shah, Shirish Sheth, Kurush Paghdiwalla, Dipti Shende and M. Aslam, Encephalitis due to ovarian dermoid, European Journal of Obstetrics & Gynecology and Reproductive Biology, 194, (256), (2015).
- Maxime Lemieux, Sylvain Chauvette and Igor Timofeev, Neocortical inhibitory activities and long-range afferents contribute to the synchronous onset of silent states of the neocortical slow oscillation, Journal of Neurophysiology, 113, 3, (768), (2015).
- André A. Fenton, Excitation-Inhibition Discoordination in Rodent Models of Mental Disorders, Biological Psychiatry, 77, 12, (1079), (2015).
- Kinga Sałat, Agata Siwek, Gabriela Starowicz, Tadeusz Librowski, Gabriel Nowak, Urszula Drabik, Ryszard Gajdosz and Piotr Popik, Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor, Neuropharmacology, 10.1016/j.neuropharm.2015.07.037, 99, (301-307), (2015).
- George A. Mashour, Noble Path to Oblivion, Anesthesiology, 122, 5, (971), (2015).
- Takeshi Fuchigami, Morio Nakayama and Sakura Yoshida, Development of PET and SPECT Probes for Glutamate Receptors, The Scientific World Journal, 2015, (1), (2015).
- S. P. Elliott, S. D. Brandt, J. Wallach, H. Morris and P. V. Kavanagh, First Reported Fatalities Associated with the 'Research Chemical' 2-Methoxydiphenidine, Journal of Analytical Toxicology, 10.1093/jat/bkv006, 39, 4, (287-293), (2015).
- R. Giorgetti, D. Marcotulli, A. Tagliabracci and F. Schifano, Effects of ketamine on psychomotor, sensory and cognitive functions relevant for driving ability, Forensic Science International, 252, (127), (2015).
- Hitomi Matsuno, Kazutaka Ohi, Ryota Hashimoto, Hidenaga Yamamori, Yuka Yasuda, Michiko Fujimoto, Satomi Yano-Umeda, Takeo Saneyoshi, Masatoshi Takeda and Yasunori Hayashi, A Naturally Occurring Null Variant of the NMDA Type Glutamate Receptor NR3B Subunit Is a Risk Factor of Schizophrenia, PLOS ONE, 10, 3, (e0116319), (2015).
- Gerard Sanacora and Alan F Schatzberg, Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?, Neuropsychopharmacology, 40, 2, (259), (2015).
- Matilda Bäckberg, Olof Beck and Anders Helander, Phencyclidine analog use in Sweden—intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project, Clinical Toxicology, 53, 9, (856), (2015).
- Lucas T. Kane and Blaise M. Costa, Identification of novel allosteric modulator binding sites in NMDA receptors: A molecular modeling study, Journal of Molecular Graphics and Modelling, 10.1016/j.jmgm.2015.06.007, 61, (204-213), (2015).
- Hamilton Morris and Jason Wallach, From PCP to MXE: a comprehensive review of the non‐medical use of dissociative drugs, Drug Testing and Analysis, 6, 7-8, (614-632), (2014).
- Anthony E. Pickering and Candida S. McCabe, Prolonged ketamine infusion as a therapy for complex regional pain syndrome: synergism with antagonism?, British Journal of Clinical Pharmacology, 77, 2, (233-238), (2014).
- Jingyi Ma and L. Stan Leung, Deep brain stimulation of the medial septum or nucleus accumbens alleviates psychosis-relevant behavior in ketamine-treated rats, Behavioural Brain Research, 10.1016/j.bbr.2014.03.010, 266, (174-182), (2014).
- H.-Q. Wu, M. Okuyama, Y. Kajii, A. Pocivavsek, J. P. Bruno and R. Schwarcz, Targeting Kynurenine Aminotransferase II in Psychiatric Diseases: Promising Effects of an Orally Active Enzyme Inhibitor, Schizophrenia Bulletin, 40, Suppl 2, (S152), (2014).
- Marleen M.H.J. van Gelder, Iris A.L.M. van Rooij, Lolkje T.W. de Jong-van den Berg and Nel Roeleveld, Teratogenic Mechanisms Associated with Prenatal Medication Exposure, Thérapie, 69, 1, (13), (2014).
- Aleksandr Rayshubskiy, Teresa J. Wojtasiewicz, Charles B. Mikell, Matthew B. Bouchard, Dmitriy Timerman, Brett E. Youngerman, Robert A. McGovern, Marc L. Otten, Peter Canoll, Guy M. McKhann and Elizabeth M.C. Hillman, Direct, intraoperative observation of ~0.1Hz hemodynamic oscillations in awake human cortex: Implications for fMRI, NeuroImage, 10.1016/j.neuroimage.2013.10.044, 87, (323-331), (2014).
- Jennifer Li, Keita Ishiwari, Michael W Conway, Jennifer Francois, John Huxter, John P Lowry, Adam J Schwarz, Mark Tricklebank and Gary Gilmour, Dissociable Effects of Antipsychotics on Ketamine-Induced Changes in Regional Oxygenation and Inter-Regional Coherence of Low Frequency Oxygen Fluctuations in the Rat, Neuropsychopharmacology, 39, 7, (1635), (2014).
- Will Lawn, Rohan Borschmann, Angela Cottrell and Adam Winstock, Methoxetamine: prevalence of use in the USA and UK and associated urinary problems, Journal of Substance Use, (1), (2014).
- Andrey B. Petrenko, Tomohiro Yamakura, Kenji Sakimura and Hiroshi Baba, Defining the role of NMDA receptors in anesthesia: Are we there yet?, European Journal of Pharmacology, 723, (29), (2014).
- Michael L. Berger, Thomas Pöhler, Oliver Schadt, Maximilian Stanger, Patrick Rebernik, Petra Scholze and Christian R. Noe, Exploring the Polyamine Regulatory Site of the NMDA Receptor: a Parallel Synthesis Approach, ChemMedChem, 8, 1, (82-94), (2012).
- Jyotshna Kanungo, Elvis Cuevas, Syed F. Ali and Merle G. Paule, Ketamine induces motor neuron toxicity and alters neurogenic and proneural gene expression in zebrafish, Journal of Applied Toxicology, 33, 6, (410-417), (2011).
- Lydia Hanna, Laura Ceolin, Sarah Lucas, James Monn, Bryan Johnson, Graham Collingridge, Zuner Bortolotto and David Lodge, Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850, an mGlu2 agonist/mGlu3 antagonist, Neuropharmacology, 66, (114), (2013).
- Jong Soo Joo, Hyun Ho Joo and In Ho Joo, Pediatric Inguinal Hernia Surgery 2,230 Cases Performed with Ketamine and Lidocaine, Journal of the Korean Association of Pediatric Surgeons, 19, 2, (73), (2013).
- ChiHye Chung, NMDA receptor as a newly identified member of the metabotropic glutamate receptor family: Clinical implications for neurodegenerative diseases, Molecules and Cells, 10.1007/s10059-013-0113-y, 36, 2, (99-104), (2013).
- Elvis Cuevas, William J. Trickler, Xiaoqing Guo, Syed F. Ali, Merle G. Paule and Jyotshna Kanungo, Acetyl l-carnitine protects motor neurons and Rohon-Beard sensory neurons against ketamine-induced neurotoxicity in zebrafish embryos, Neurotoxicology and Teratology, 39, (69), (2013).
- Eiichi Jodo, The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: A model for schizophrenia, Journal of Physiology-Paris, 107, 6, (434), (2013).
- Ting-Ting Duan, Ji-Wei Tan, Qiang Yuan, Jun Cao, Qi-Xin Zhou and Lin Xu, Acute ketamine induces hippocampal synaptic depression and spatial memory impairment through dopamine D1/D5 receptors, Psychopharmacology, 10.1007/s00213-013-3048-2, 228, 3, (451-461), (2013).
- Vincenzo Tedesco, Chiara Ravagnani, Daniele Bertoglio and Cristiano Chiamulera, Acute ketamine-induced neuroplasticity, NeuroReport, 24, 7, (388), (2013).
- Paul Garcia, Matthew Keith Whalin and Peter S. Sebel, Intravenous Anesthetics, Pharmacology and Physiology for Anesthesia, 10.1016/B978-1-4377-1679-5.00009-0, (137-158), (2013).
- Robin M. Murray, Alessandra Paparelli, Paul D. Morrison, Arianna Marconi and Marta Di Forti, What can we learn about schizophrenia from studying the human model, drug‐induced psychosis?, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 162, 7, (661-670), (2013).
- Cara A. Jennings, Barton T. Bobb, Danielle M. Noreika and Patrick J. Coyne, Oral Ketamine for Sickle Cell Crisis Pain Refractory to Opioids, Journal of Pain & Palliative Care Pharmacotherapy, 27, 2, (150), (2013).
- Naomi R Driesen, Gregory McCarthy, Zubin Bhagwagar, Michael H Bloch, Vincent D Calhoun, Deepak C D'Souza, Ralitza Gueorguieva, George He, Hoi-Chung Leung, Ramachandran Ramani, Alan Anticevic, Raymond F Suckow, Peter T Morgan and John H Krystal, The Impact of NMDA Receptor Blockade on Human Working Memory-Related Prefrontal Function and Connectivity, Neuropsychopharmacology, 10.1038/npp.2013.170, 38, 13, (2613-2622), (2013).
- Francois Gastambide, Gary Gilmour, Trevor W. Robbins and Mark D. Tricklebank, The mGlu5 positive allosteric modulator LSN2463359 differentially modulates motor, instrumental and cognitive effects of NMDA receptor antagonists in the rat, Neuropharmacology, 64, (240), (2013).
- Francesca Sori, Noemi Romagnoli, Domenico Ferrara, Anna Zaghini and Paola Roncada, Plasma and Red Blood Cells Concentration Profiles of Ktamine after Single Intravenous Administration in an Anaesthetic Protocol in Horses, Open Journal of Veterinary Medicine, 03, 02, (136), (2013).
- James R. Hinman, Stephanie C. Penley, Monty A. Escabí and James J. Chrobak, Ketamine disrupts theta synchrony across the septotemporal axis of the CA1 region of hippocampus, Journal of Neurophysiology, 109, 2, (570), (2013).
- Gokhan Ordek, Jonathan D. Groth and Mesut Sahin, Differential effects of ketamine/xylazine anesthesia on the cerebral and cerebellar cortical activities in the rat, Journal of Neurophysiology, 109, 5, (1435), (2013).
- Xin Wang, António Pinto-Duarte, Terrence J. Sejnowski and M. Margarita Behrens, How Nox2-Containing NADPH Oxidase Affects Cortical Circuits in the NMDA Receptor Antagonist Model of Schizophrenia, Antioxidants & Redox Signaling, 10.1089/ars.2012.4907, 18, 12, (1444-1462), (2013).
- Pei-Lu Yi, Chin-Yu Lu, Chiung-Hsiang Cheng, Yi-Fong Tsai, Chung-Tien Lin and Fang-Chia Chang, Amygdala opioid receptors mediate the electroacupuncture-induced deterioration of sleep disruptions in epilepsy rats, Journal of Biomedical Science, 20, 1, (85), (2013).
- Richard G.M. Morris, NMDA receptors and memory encoding, Neuropharmacology, 74, (32), (2013).
- E. PONTÉN, H. VIBERG, T. GORDH, P. ERIKSSON and A. FREDRIKSSON, Clonidine abolishes the adverse effects on apoptosis and behaviour after neonatal ketamine exposure in mice, Acta Anaesthesiologica Scandinavica, 56, 8, (1058-1065), (2012).
- Gerard J. Marek, Bruce J. Kinon, David L. McKinzie, Jeffrey M. Schkeryantz and James A. Monn, Metabotropic Glutamate 2/3 Receptor Agonists and Positive Allosteric Modulators of Metabotropic Glutamate Receptor 2 as Novel Agents for the Treatment of Schizophrenia, Targets and Emerging Therapies for Schizophrenia, (143-185), (2012).
- Golam M.I. Chowdhury, Kevin L. Behar, William Cho, Monique A. Thomas, Douglas L. Rothman and Gerard Sanacora, 1H-[13C]-Nuclear Magnetic Resonance Spectroscopy Measures of Ketamine's Effect on Amino Acid Neurotransmitter Metabolism, Biological Psychiatry, 71, 11, (1022), (2012).
- P. Fusar-Poli, P. McGuire and S. Borgwardt, Mapping prodromal psychosis: A critical review of neuroimaging studies, European Psychiatry, 27, 3, (181), (2012).
- Luis M. Traverso, Gabriel Ruiz and Luis G. De la Casa, MK-801 induces a low intensity conditioned taste aversion, Pharmacology Biochemistry and Behavior, 100, 3, (645), (2012).
- Joseph T. Coyle, Alo Basu and Michael Benneyworth, Glutamatergic Synaptic Dysregulation in Schizophrenia, Targets and Emerging Therapies for Schizophrenia, (115-142), (2012).
- Ben A. Chindo, Bulus Adzu, Tijani A. Yahaya and Karniyus S. Gamaniel, Ketamine-enhanced immobility in forced swim test: A possible animal model for the negative symptoms of schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 38, 2, (310), (2012).
- B. Martinac and A. Kloda, 6.5 Mechanosensory Transduction, Comprehensive Biophysics, 10.1016/B978-0-12-374920-8.00618-4, (108-141), (2012).
- M. Neukirchen, J. Hipp, M.S. Schaefer, T. Brandenburger, I. Bauer, M. Winterhalter, P. Kienbaum and R. Werdehausen, Cardiovascular stability and unchanged muscle sympathetic activity during xenon anaesthesia: role of norepinephrine uptake inhibition, British Journal of Anaesthesia, 109, 6, (887), (2012).
- Matthias Eikermann, Martina Grosse-Sundrup, Sebastian Zaremba, Mark E. Henry, Edward A. Bittner, Ulrike Hoffmann and Nancy L. Chamberlin, Ketamine Activates Breathing and Abolishes the Coupling between Loss of Consciousness and Upper Airway Dilator Muscle Dysfunction, Anesthesiology, 116, 1, (35), (2012).
- Sanjay J. Mathew, Asim Shah, Kyle Lapidus, Crystal Clark, Noor Jarun, Britta Ostermeyer and James W. Murrough, Ketamine for Treatment-Resistant Unipolar Depression, CNS Drugs, 10.2165/11599770-000000000-00000, 26, 3, (189-204), (2012).
- ChiHye Chung, New perspectives on glutamate receptor antagonists as antidepressants, Archives of Pharmacal Research, 35, 4, (573), (2012).
- R.A. Felix, A. Kadner and A.S. Berrebi, Effects of ketamine on response properties of neurons in the superior paraolivary nucleus of the mouse, Neuroscience, 201, (307), (2012).
- R. Haseneder, E. Kochs and B. Jungwirth, Postoperative kognitive Dysfunktion, Der Anaesthesist, 61, 5, (437), (2012).
- Jens Köhler, Klaus Bergander, Jörg Fabian, Dirk Schepmann and Bernhard Wünsch, Enantiomerically Pure 1,3-Dioxanes as Highly Selective NMDA and σ1 Receptor Ligands, Journal of Medicinal Chemistry, 55, 20, (8953), (2012).
- Osamu Saito, Toru Akagi, Mai Tatsuno, Kosuke Miura, Chio Shuto, Naoko Kudo, Satoshi Murakami and Motohiro Matoba, A small amount of ketamine with oxycodone induced an acute hyperactive delirium due to voriconazole, a CYP3A4 inhibitor, in a case of multiple myeloma with cancer pain, Palliative Care Research, 7, 1, (506), (2012).
- J. T. Coyle, NMDA Receptor and Schizophrenia: A Brief History, Schizophrenia Bulletin, 38, 5, (920), (2012).
- Maryam Moosavi, Golnaz Yadollahi Khales, Karim Rastegar and Asadollah Zarifkar, The effect of sub-anesthetic and anesthetic ketamine on water maze memory acquisition, consolidation and retrieval, European Journal of Pharmacology, 677, 1-3, (107), (2012).
- Robert Schwarcz, John P. Bruno, Paul J. Muchowski and Hui-Qiu Wu, Kynurenines in the mammalian brain: when physiology meets pathology, Nature Reviews Neuroscience, 13, 7, (465), (2012).
- Chiung-Hsiang Cheng, Pei-Lu Yi, Han-Han Chang, Yi-Fong Tsai and Fang-Chia Chang, Kappa-Opioid Receptors in the Caudal Nucleus Tractus Solitarius Mediate 100 Hz Electroacupuncture-Induced Sleep Activities in Rats, Evidence-Based Complementary and Alternative Medicine, 2012, (1), (2012).
- Christian P. Müller, Martin E. Pum, Davide Amato, Jürgen Schüttler, Joseph P. Huston and Maria A. De Souza Silva, The in vivo neurochemistry of the brain during general anesthesia, Journal of Neurochemistry, 119, 3, (419-446), (2011).
- H. Kawano, E. Hamaguchi, S. Kawahito, Y. M. Tsutsumi, K. Tanaka, H. Kitahata and S. Oshita, Anaesthesia for a patient with paraneoplastic limbic encephalitis with ovarian teratoma: relationship to anti‐N‐methyl‐d‐aspartate receptor antibodies, Anaesthesia, 66, 6, (515-518), (2011).
- Ki-Cheol Sim, Gi-Do Kim, Kyung-Yoon Kim, Ho-Jung An, Joon-Hee Lee, Kyoung-Ok Min and Gye-Yeop Kim, The Effects of tDCS and Montoya Stair Task on Sensorimotor Recovery and GFAP Expression in MCAo induced Stroke Rat Model, Journal of International Academy of Physical Therapy Research, 2, 1, (193), (2011).
- Toru Nishikawa, Analysis of free d-serine in mammals and its biological relevance, Journal of Chromatography B, 879, 29, (3169), (2011).
- Samantha L Rushforth, Thomas Steckler and Mohammed Shoaib, Nicotine Improves Working Memory Span Capacity in Rats Following Sub-Chronic Ketamine Exposure, Neuropsychopharmacology, 36, 13, (2774), (2011).
- Chiung-Hsiang Cheng, Pei-Lu Yi, Jaung-Geng Lin and Fang-Chia Chang, Endogenous Opiates in the Nucleus Tractus Solitarius Mediate Electroacupuncture-Induced Sleep Activities in Rats, Evidence-Based Complementary and Alternative Medicine, 2011, (1), (2011).
- Peter K. Hatemi, Nathan A. Gillespie, Lindon J. Eaves, Brion S. Maher, Bradley T. Webb, Andrew C. Heath, Sarah E. Medland, David C. Smyth, Harry N. Beeby, Scott D. Gordon, Grant W. Montgomery, Ghu Zhu, Enda M. Byrne and Nicholas G. Martin, A Genome-Wide Analysis of Liberal and Conservative Political Attitudes, The Journal of Politics, 73, 1, (271), (2011).
- Maria Teresa De Luca and Aldo Badiani, Ketamine self-administration in the rat: evidence for a critical role of setting, Psychopharmacology, 214, 2, (549), (2011).
- Chun-Ping Chu, Yan-Hua Bing and De-Lai Qiu, Sensory stimulus evokes inhibition rather than excitation in cerebellar Purkinje cells in vivo in mice, Neuroscience Letters, 487, 2, (182), (2011).
- Melanie J. P. Fraites and Charles E. Wood, Chemoreflex Activity Increases Prostaglandin Endoperoxide Synthase mRNA Expression in the Late-Gestation Fetal Sheep Brain, Reproductive Sciences, 18, 9, (824), (2011).
- Philip R Corlett, Garry D Honey, John H Krystal and Paul C Fletcher, Glutamatergic Model Psychoses: Prediction Error, Learning and Inference, Neuropsychopharmacology, 36, 1, (294), (2011).
- Sarbjeet S. Kalsi, David M. Wood and Paul I. Dargan, The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use, Emerging Health Threats Journal, 4, 1, (7107), (2011).
- Markus R Meyer and Hans H Maurer, Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse, Pharmacogenomics, 10.2217/pgs.10.171, 12, 2, (215-233), (2011).
- Kevin K. Ogden and Stephen F. Traynelis, New advances in NMDA receptor pharmacology, Trends in Pharmacological Sciences, 32, 12, (726), (2011).
- René A. W. Frank, Allan F. McRae, Andrew J. Pocklington, Louie N. van de Lagemaat, Pau Navarro, Mike D. R. Croning, Noboru H. Komiyama, Sophie J. Bradley, R. A. John Challiss, J. Douglas Armstrong, Robert D. Finn, Mary P. Malloy, Alan W. MacLean, Sarah E. Harris, John M. Starr, Sanjeev S. Bhaskar, Eleanor K. Howard, Sarah E. Hunt, Alison J. Coffey, Venkatesh Ranganath, Panos Deloukas, Jane Rogers, Walter J. Muir, Ian J. Deary, Douglas H. Blackwood, Peter M. Visscher, Seth G. N. Grant and Thomas Burne, Clustered Coding Variants in the Glutamate Receptor Complexes of Individuals with Schizophrenia and Bipolar Disorder, PLoS ONE, 6, 4, (e19011), (2011).
- Antonia Reimer, Peter Hubka, Andreas K. Engel and Andrej Kral, Fast Propagating Waves within the Rodent Auditory Cortex, Cerebral Cortex, 21, 1, (166), (2011).
- Eckehard A.E. Stuth, Astrid G. Stucke and Edward J. Zuperku, Effects of Anesthetics, Sedatives, and Opioids on Ventilatory Control, Comprehensive Physiology, (2281-2367), (2012).
- S.N. Lee, L. Li and Z. Zuo, Glutamate transporter type 3 knockout mice have a decreased isoflurane requirement to induce loss of righting reflex, Neuroscience, 171, 3, (788), (2010).
- KY Chan, S Gupta, R de Vries, AHJ Danser, CM Villalón, E Muñoz‐Islas and A MaassenVanDenBrink, Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model, British Journal of Pharmacology, 160, 6, (1316-1325), (2010).
- M. M. H. J. van Gelder, I. A. L. M. van Rooij, R. K. Miller, G. A. Zielhuis, L. T. W. de Jong-van den Berg and N. Roeleveld, Teratogenic mechanisms of medical drugs, Human Reproduction Update, 16, 4, (378), (2010).
- W Andrew Kofke, Anesthetic management of the patient with epilepsy or prior seizures, Current Opinion in Anaesthesiology, 23, 3, (391), (2010).
- Yoko Hagino, Shinya Kasai, Wenhua Han, Hideko Yamamoto, Toshitaka Nabeshima, Masayoshi Mishina, Kazutaka Ikeda and Kenji Hashimoto, Essential Role of NMDA Receptor Channel ε4 Subunit (GluN2D) in the Effects of Phencyclidine, but Not Methamphetamine, PLoS ONE, 5, 10, (e13722), (2010).
- Sheng Peng, Yan Zhang, Jiannan Zhang, Hua Wang and Bingxu Ren, Effect of ketamine on ERK expression in hippocampal neural cell and the ability of learning behavior in minor rats, Molecular Biology Reports, 37, 7, (3137), (2010).
- Erik H. F. Wong, Frank Yocca, Mark A. Smith and Chi-Ming Lee, Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective, The International Journal of Neuropsychopharmacology, 10.1017/S1461145710000866, 13, 09, (1269-1284), (2010).
- Ulf Madsen, Hans Bräuner‐Osborne, Jeremy R. Greenwood, Tommy N. Johansen, Povl Krogsgaard‐Larsen, Tommy Liljefors, Mogens Nielsen and Bente Frølund, GABA and Glutamate Receptor Ligands and their Therapeutic Potential in CNS Disorders, Pharmaceutical Sciences Encyclopedia, (1-111), (2010).
- Franz X. Vollenweider and Michael Kometer, The neurobiology of psychedelic drugs: implications for the treatment of mood disorders, Nature Reviews Neuroscience, 11, 9, (642), (2010).
- Ricardo Jorge Dinis-Oliveira, Félix Carvalho, José Alberto Duarte, Ricardo Dias, Teresa Magalhães and Agostinho Santos, Suicide by hanging under the influence of ketamine and ethanol, Forensic Science International, 202, 1-3, (e23), (2010).
- R. von Haken, M. Gruß, K. Plaschke, M. Scholz, R. Engelhardt, A. Brobeil, E. Martin and M.A. Weigand, Delir auf der Intensivstation, Der Anaesthesist, 59, 3, (235), (2010).
- Geraldine Dowling, Liam Regan, Julie Tierney and Michael Nangle, A hybrid liquid chromatography–mass spectrometry strategy in a forensic laboratory for opioid, cocaine and amphetamine classes in human urine using a hybrid linear ion trap-triple quadrupole mass spectrometer, Journal of Chromatography A, 10.1016/j.chroma.2010.08.043, 1217, 44, (6857-6866), (2010).
- Pierre Pouget, Nicolas Wattiez, Sophie Rivaud-Péchoux and Bertrand Gaymard, Rapid development of tolerance to sub-anaesthetic dose of ketamine: an oculomotor study in macaque monkeys, Psychopharmacology, 209, 4, (313), (2010).
- You-Yin Chen, Yen-Yu I. Shih, Yu-Chun Lo, Pen-Li Lu, Siny Tsang, Fu-Shan Jaw and Ren-Shyan Liu, MicroPET imaging of noxious thermal stimuli in the conscious rat brain, Somatosensory & Motor Research, 27, 3, (69), (2010).
- V.-S. Eckle, C. Hucklenbruch and S.M. Todorovic, Was wissen wir über Narkosemechanismen?, Der Anaesthesist, 58, 11, (1144), (2009).
- Jiang H. Ye, Kimberly A. Sokol and Urvi Bhavsar, Glycine Receptors Contribute to Hypnosis Induced by Ethanol, Alcoholism: Clinical and Experimental Research, 33, 6, (1069-1074), (2009).
- Michele Bellesi, Marcello Melone, Alessandro Gubbini, Silvia Battistacci and Fiorenzo Conti, GLT‐1 upregulation impairs prepulse inhibition of the startle reflex in adult rats, Glia, 57, 7, (703-713), (2008).
- David Lodge, The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature, Neuropharmacology, 56, 1, (6), (2009).
- Chantal Schlumberger, Daniela Schäfer, Caroline Barberi, Lorenzo Morè, Jens Nagel, Małgorzata Pietraszek, Werner J. Schmidt and Wojciech Danysz, Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition, Behavioural Pharmacology, 20, 1, (56), (2009).
- Jai Yun Jung, Jun Ho Lee, Jeong Seok Lee and Yong Ik Kim, The Effect of a Target Controlled Infusion of Low-Concentration Ketamine on the Heart Rate Variability of Normal Volunteers, The Korean Journal of Pain, 22, 1, (39), (2009).
- H K Caldwell, S L Stephens and W S Young, Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice, Molecular Psychiatry, 14, 2, (190), (2009).
- P. R. Corlett, C. D. Frith and P. C. Fletcher, From drugs to deprivation: a Bayesian framework for understanding models of psychosis, Psychopharmacology, 206, 4, (515), (2009).
- Nikolaos Pitsikas and Antonios Boultadakis, Pre-training administration of anesthetic ketamine differentially affects rats' spatial and non-spatial recognition memory, Neuropharmacology, 57, 1, (1), (2009).
- Handan Gunduz-Bruce, The acute effects of NMDA antagonism: From the rodent to the human brain, Brain Research Reviews, 60, 2, (279), (2009).
- Kyung-A Son, Ji-Houn Kang and Mhan-Pyo Yang, Ketamine inhibits the phagocytic responses of canine peripheral blood polymorphonuclear cells through the upregulation of prostaglandin E2 in peripheral blood mononuclear cells in vitro, Research in Veterinary Science, 87, 1, (41), (2009).
- Philip M. Finch, Lone Knudsen and Peter D. Drummond, Reduction of allodynia in patients with complex regional pain syndrome: A double-blind placebo-controlled trial of topical ketamine, Pain, 146, 1, (18), (2009).
- A. LacKamp, G.-C. Zhang, L.-M. Mao, E.E. Fibuch and J.Q. Wang, Loss of surface N -methyl- d -aspartate receptor proteins in mouse cortical neurones during anaesthesia induced by chloral hydrate in vivo, British Journal of Anaesthesia, 102, 4, (515), (2009).
- Nobuyuki Matsuura, Yoshiyuki Shibukawa, Motoichiro Kato, Tatsuya Ichinohe, Takashi Suzuki and Yuzuru Kaneko, Ketamine, not fentanyl, suppresses pain-related magnetic fields associated with trigeminally innervated area following CO2 laser stimulation, Neuroscience Research, 62, 2, (105), (2008).
- Noelle C. Anastasio and Kenneth M. Johnson, Differential regulation of the NMDA receptor by acute and sub‐chronic phencyclidine administration in the developing rat, Journal of Neurochemistry, 104, 5, (1210-1218), (2007).
- Alke K Enderle, Olivier L Levionnois, Matthias Kuhn and Urs Schatzmann, Clinical evaluation of ketamine and lidocaine intravenous infusions to reduce isoflurane requirements in horses under general anaesthesia, Veterinary Anaesthesia and Analgesia, 35, 4, (297-305), (2008).
- Giorgia Fattorini, Marcello Melone, Luca Bragina, Chiara Candiracci, Andrea Cozzi, Domenico E. Pellegrini Giampietro, Monica Torres‐Ramos, Alberto Pérez‐Samartín, Carlos Matute and Fiorenzo Conti, GLT‐1 expression and Glu uptake in rat cerebral cortex are increased by phencyclidine, Glia, 56, 12, (1320-1327), (2008).
- Mark S. Wallace and Gery Schulteis, Effect of Chronic Oral Gabapentin on Capsaicin-induced Pain and Hyperalgesia, The Clinical Journal of Pain, 24, 6, (544), (2008).
- David Jane and Daniel Monaghan, Pharmacology of NMDA Receptors, Biology of the NMDA Receptor, 10.1201/9781420044157.ch12, (257-281), (2009).
- Bhooma R. Aravamuthan, Debra A. Bergstrom, Robin A. French, Joseph J. Taylor, Louise C. Parr-Brownlie and Judith R. Walters, Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson's disease, Experimental Neurology, 213, 2, (268), (2008).
- C. Monier, J. Fournier and Y. Frégnac, In vitro and in vivo measures of evoked excitatory and inhibitory conductance dynamics in sensory cortices, Journal of Neuroscience Methods, 169, 2, (323), (2008).
- Daniel D. Kurylo and Yunglin Gazes, Effects of Ketamine on perceptual grouping in rats, Physiology & Behavior, 95, 1-2, (152), (2008).
- Jonathan D. Reasor and Gina R. Poe, Learning and Memory During Sleep and Anesthesia, International Anesthesiology Clinics, 46, 3, (105), (2008).
- Keith A. Trujillo, Juan J. Zamora and Kathleen P. Warmoth, Increased Response to Ketamine Following Treatment at Long Intervals: Implications for Intermittent Use, Biological Psychiatry, 63, 2, (178), (2008).
- Sung-Yong Park, Myoung-Sin Seo, Hie-Young Kim, Mie-Hyun Park, Jeong Woong Choi and Sook Young Lee, The individual and combined neuroprotective effects of propofol and ketamine on rat mixed cortical cultures exposed to oxygen-glucose deprivation-reperfusion injury, Korean Journal of Anesthesiology, 55, 1, (72), (2008).
- Gang Lei, Yan Xia and Kenneth M Johnson, The Role of Akt-GSK-3β Signaling and Synaptic Strength in Phencyclidine-Induced Neurodegeneration, Neuropsychopharmacology, 10.1038/sj.npp.1301511, 33, 6, (1343-1353), (2007).
- Věra Bubeníková-Valešová, Jiří Horáček, Monika Vrajová and Cyril Höschl, Models of schizophrenia in humans and animals based on inhibition of NMDA receptors, Neuroscience & Biobehavioral Reviews, 32, 5, (1014), (2008).
- Xiaoguang Zhang, Zhanggang Xue and Anyang Sun, Subclinical concentration of sevoflurane potentiates neuronal apoptosis in the developing C57BL/6 mouse brain, Neuroscience Letters, 447, 2-3, (109), (2008).
- Mark C. Parkin, Sophie C. Turfus, Norman W. Smith, John M. Halket, Robin A. Braithwaite, Simon P. Elliott, M. David Osselton, David A. Cowan and Andrew T. Kicman, Detection of ketamine and its metabolites in urine by ultra high pressure liquid chromatography–tandem mass spectrometry, Journal of Chromatography B, 876, 1, (137), (2008).
- Robert Wöhrl, Sven Eisenach, Denise Manahan‐Vaughan, Uwe Heinemann and Dorothea Von Haebler, Acute and long‐term effects of MK‐801 on direct cortical input evoked homosynaptic and heterosynaptic plasticity in the CA1 region of the female rat, European Journal of Neuroscience, 26, 10, (2873-2883), (2007).
- David Bleakman, Andrew Alt, David Lodge, Daniel T. Monaghan, David E. Jane and Eric S. Nisenbaum, Ionotropic Glutamate Receptors, Handbook of Contemporary Neuropharmacology, (2007).
- Suzanne White, Treatment of Carbon Monoxide Poisoning, Carbon Monoxide Poisoning, 10.1201/9780849384189.ch16, (341-374), (2010).
- Peter H. Boeijinga, L. Soufflet, F. Santoro and R. Luthringer, Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man, Journal of Psychopharmacology, 21, 3, (321), (2007).
- Melanie J. Powers and Charles E. Wood, Ketamine inhibits fetal ACTH responses to cerebral hypoperfusion, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 292, 4, (R1542), (2007).
- James M. Stone, Paul D. Morrison and Lyn S. Pilowsky, Review: Glutamate and dopamine dysregulation in schizophrenia — a synthesis and selective review, Journal of Psychopharmacology, 21, 4, (440), (2007).
- Masahiro Irifune, Nobuhito Kikuchi, Takuya Saida, Tohru Takarada, Yoshitaka Shimizu, Chie Endo, Katsuya Morita, Toshihiro Dohi, Tomoaki Sato and Michio Kawahara, Riluzole, a Glutamate Release Inhibitor, Induces Loss of Righting Reflex, Antinociception, and Immobility in Response to Noxious Stimulation in Mice, Anesthesia & Analgesia, 104, 6, (1415), (2007).
- Adnan T. Bhutta, Ketamine: A Controversial Drug for Neonates, Seminars in Perinatology, 31, 5, (303), (2007).
- Fredrik Bengtsson and Henrik Jörntell, Ketamine and Xylazine Depress Sensory-Evoked Parallel Fiber and Climbing Fiber Responses, Journal of Neurophysiology, 98, 3, (1697), (2007).
- Boris A. Chizh, Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways, Journal of Psychopharmacology, 21, 3, (259), (2007).
- Peter S. Spencer, J. Hugon, A. Ludolph, P. B. Nunn, S. M. Ross, D. N. Roy and H. H. Schaumburg, Discovery and Partial Characterization of Primate Motor‐System Toxins, Ciba Foundation Symposium 126 ‐ Selective Neuronal Death, (221-238), (2007).
- Gunvant K Thaker, Schizophrenia endophenotypes as treatment targets, Expert Opinion on Therapeutic Targets, 11, 9, (1189), (2007).
- Jean‐Michel Arrang, Histamine and Schizophrenia, Integrating the Neurobiology of Schizophrenia, 10.1016/S0074-7742(06)78009-6, (247-287), (2007).
- Masahiro Irifune, Sohtaro Katayama, Tohru Takarada, Yoshitaka Shimizu, Chie Endo, Takashi Takata, Katsuya Morita, Toshihiro Dohi, Tomoaki Sato and Michio Kawahara, MK-801 enhances gabaculine-induced loss of the righting reflex in mice, but not immobility, Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 54, 12, (998), (2007).
- Mitsuo Tanabe, Inhibition of hyperpolarization-activated cation currents by phencyclidine and some sigma ligands in rat hippocampal CA1 pyramidal neurons in vitro, Neuropharmacology, 53, 3, (406), (2007).
- B. Moghaddam and J.H. Krystal, The Neurochemistry of Schizophrenia, Schizophrenia, (349-364), (2007).
- Tsuneo Takadera, Akira Ishida and Takao Ohyashiki, Ketamine-induced apoptosis in cultured rat cortical neurons, Toxicology and Applied Pharmacology, 210, 1-2, (100), (2006).
- Raphaël Faucard, Vincent Armand, Anne Héron, Véronique Cochois, Jean‐Charles Schwartz and Jean‐Michel Arrang, N‐methyl‐d‐aspartate receptor antagonists enhance histamine neuron activity in rodent brain, Journal of Neurochemistry, 98, 5, (1487-1496), (2006).
- Bruce Jenkins, Joseph Mandeville and Yin-Ching Chen, Pharmacologic Magnetic Resonance Imaging (phMRI), In Vivo MR Techniques in Drug Discovery and Development, 10.3109/9781420004526-16, (171-220), (2013).
- Clare L. Littlewood, Diana Cash, Aisling L. Dixon, Sophie L. Dix, Craig T. White, Michael J. O'Neill, Mark Tricklebank and Steven C.R. Williams, Using the BOLD MR signal to differentiate the stereoisomers of ketamine in the rat, NeuroImage, 10.1016/j.neuroimage.2006.05.022, 32, 4, (1733-1746), (2006).
- Clare L. Littlewood, Nicholas Jones, Michael J. O’Neill, Stephen N. Mitchell, Mark Tricklebank and Steven C. R. Williams, Mapping the central effects of ketamine in the rat using pharmacological MRI, Psychopharmacology, 10.1007/s00213-006-0344-0, 186, 1, (64-81), (2006).
- Adrian M. Solano, Bruno H. Pypendop, Pedro L. Boscan and Jan E. Ilkiw, Effect of intravenous administration of ketamine on the minimum alveolar concentration of isoflurane in anesthetized dogs, American Journal of Veterinary Research, 67, 1, (21), (2006).
- Jennifer L. Lucitti and Michael S. Hedrick, Characterization of baroreflex gain in the domestic pigeon (Columba livia), Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 143, 1, (103), (2006).
- Kim Wolff and Adam R Winstock, Ketamine, CNS Drugs, 20, 3, (199), (2006).
- S. Shibuta, S. Varathan and T. Mashimo, Ketamine and thiopental sodium: individual and combined neuroprotective effects on cortical cultures exposed to NMDA or nitric oxide, British Journal of Anaesthesia, 97, 4, (517), (2006).
- Francois J. Smith, Peter R. Bartel, Johan M. Hugo and Pieter J. Becker, Anesthetic Technique (Sufentanil Versus Ketamine Plus Midazolam) and Quantitative Electroencephalographic Changes After Cardiac Surgery, Journal of Cardiothoracic and Vascular Anesthesia, 20, 4, (520), (2006).
- C A Tamminga and H H Holcomb, Phenotype of schizophrenia: a review and formulation, Molecular Psychiatry, 10, 1, (27), (2005).
- Takashi Itoh, Shunichi Wakahara, Takayuki Nakano, Kazutoshi Suzuki, Kaoru Kobayashi and Osamu Inoue, Effects of anesthesia upon18F-FDG uptake in rhesus monkey brains, Annals of Nuclear Medicine, 19, 5, (373), (2005).
- Tomohiro Yamakura, Ahmed R. Askalany, Andrey B. Petrenko, Tatsuro Kohno, Hiroshi Baba and Kenji Sakimura, The NR3B Subunit Does Not Alter the Anesthetic Sensitivities of Recombinant N-Methyl-d-Aspartate Receptors, Anesthesia & Analgesia, 100, 6, (1687), (2005).
- Daniel Klamer, Jianhua Zhang, Jörgen A. Engel and Lennart Svensson, Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat, Behavioural Brain Research, 159, 1, (95), (2005).
- Jan Copeland and Paul Dillon, The health and psycho-social consequences of ketamine use, International Journal of Drug Policy, 16, 2, (122), (2005).
- Miki KANEUCHI, Naonori KOHRI, Kaname SENBONGI, Hideo SAKAI and Ken ISEKI, Preparing and Evaluation of Oral Dosage Form of Ketamine Considering Simplicity for Preparation in Hospital and Ease for Patients to Take (1) —Preparations Using Agar—, YAKUGAKU ZASSHI, 125, 2, (187), (2005).
- Boris S. Zhorov and Denis B. Tikhonov, Potassium, sodium, calcium and glutamate‐gated channels: pore architecture and ligand action, Journal of Neurochemistry, 88, 4, (782-799), (2004).
- Věra Bubeníková, Jiří Horáček, Jiří Kožený, Veronika Platilová, Lucie Závěšická, Tomáš Páleníček and Cyril Höschl, The effect of tryptophan depletion on the action of haloperidol in MK-801-treated rats, European Journal of Pharmacology, 502, 1-2, (109), (2004).
- Nobuyuki Matsuura, Yoshiyuki Shibukawa, Tatsuya Ichinohe, Takashi Suzuki and Yuzuru Kaneko, Ketamine inhibits pain-SEFs following CO2 laser stimulation on trigeminally innervated skin region: a magnetoencephalographic study, International Congress Series, 1270, (121), (2004).
- Hui-Dong Wang, Jian-Yong Hu and Morikuni Takigawa, The blockade by phencyclidine of glutamate-induced intracellular calcium increase in cultured neocortical neurons, Brain Research, 1001, 1-2, (164), (2004).
- Kinga K. Borowicz, Jarogniew Ł and Stanisaw J. Czuczwar, Interactions between non-barbiturate injectable anesthetics and conventional antiepileptic drugs in the maximal electroshock test in mice—an isobolographic analysis, European Neuropsychopharmacology, 14, 2, (163), (2004).
- Edward J. Calabrese and Linda A. Baldwin, Inorganics and Hormesis, Critical Reviews in Toxicology, 33, 3-4, (215), (2003).
- Julian S Taylor and Charles J Vierck, Effects of ketamine on electroencephalographic and autonomic arousal and segmental reflex responses in the cat, Veterinary Anaesthesia and Analgesia, 30, 4, (237-249), (2003).
- V. Di Lazzaro, A. Oliviero, P. Profice, M. A. Pennisi, F. Pilato, G. Zito, M. Dileone, R. Nicoletti, P. Pasqualetti and P.A. Tonali, Ketamine Increases Human Motor Cortex Excitability to Transcranial Magnetic Stimulation, The Journal of Physiology, 547, 2, (485-496), (2004).
- Michael A. Rogawski and Gary L. Wenk, The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease, CNS Drug Reviews, 9, 3, (275-308), (2006).
- Mauro Fà, Giampaolo Mereu, Veronica Ghiglieri, Alessandra Meloni, Paola Salis and Gian Luigi Gessa, Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head‐restrained rat, Synapse, 48, 1, (1-9), (2003).
- GERARD SANACORA, DOUGLAS L. ROTHMAN, GRAEME MASON and JOHN H. KRYSTAL, Clinical Studies Implementing Glutamate Neurotransmission in Mood Disorders, Annals of the New York Academy of Sciences, 1003, 1, (292-308), (2006).
- R. Dickinson, S. Awaiz, M.A. Whittington, W.R. Lieb and N.P. Franks, The effects of general anaesthetics on carbachol-evoked gamma oscillations in the rat hippocampus in vitro, Neuropharmacology, 44, 7, (864), (2003).
- C. Anthony Altar, Arnold R. Martin and Andrew Thurkauf, Antipsychotic Agents, Burger's Medicinal Chemistry and Drug Discovery, (599-672), (2003).
- Ratna Sircar and Karam F.A Soliman, Effects of postnatal PCP treatment on locomotor behavior and striatal D2 receptor, Pharmacology Biochemistry and Behavior, 74, 4, (943), (2003).
- Kinga K Borowicz and Stanisław J Czuczwar, Effects of etomidate, ketamine or propofol, and their combinations with conventional antiepileptic drugs on amygdala-kindled convulsions in rats, Neuropharmacology, 45, 3, (315), (2003).
- Arvid Carlsson, Historical aspects and future directions, Dopamine in the Pathophysiology and Treatment of Schizophrenia, 10.3109/9780203427347-2, (1-13), (2013).
- Jeff Gelblum, Profile of Ketamine, CPP, Dextromethorphan, and Memantine, Pain, 10.1201/9780203911259.ch46, (2009).
- John H. Krystal, Ismene L. Petrakis, Graeme Mason, Louis Trevisan and D.Cyril D'Souza, N-methyl-d-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability, Pharmacology & Therapeutics, 99, 1, (79), (2003).
- Sarah M Turgeon and Stephen G Hoge, Prior exposure to phencyclidine decreases voluntary sucrose consumption and operant performance for food reward, Pharmacology Biochemistry and Behavior, 76, 3-4, (393), (2003).
- William W. Muir III, Ashley J. Wiese and Philip A. March, Effects of morphine, lidocaine, ketamine, and morphine-lidocaine-ketamine drug combination on minimum alveolar concentration in dogs anesthetized with isoflurane, American Journal of Veterinary Research, 64, 9, (1155), (2003).
- Boris Chizh and P Max Headley, N-Methyl-D-Aspartate (NMDA) Receptors as a Target for Pain Therapy, Pain, 10.1201/9780203911259.ch45, (2009).
- CAROL A. TAMMINGA, ADRIENNE C. LAHTI, DEBORAH R. MEDOFF, XUE‐MIN GAO and HENRY H. HOLCOMB, Evaluating Glutamatergic Transmission in Schizophrenia, Annals of the New York Academy of Sciences, 1003, 1, (113-118), (2006).
- Jennifer C. Quirk and Eric S. Nisenbaum, LY404187: A Novel Positive Allosteric Modulator of AMPA Receptors, CNS Drug Reviews, 8, 3, (255-282), (2006).
- Jahangir Maleki, “Sensitization”: Is There a Cure?, Pain Medicine, 3, 4, (294-297), (2002).
- Ranjinidevi Ambalavanar, Laura Purcell, Marcia Miranda, Frank Evans and Christy L. Ludlow, Selective Suppression of Late Laryngeal Adductor Responses by N-Methyl-d-Aspartate Receptor Blockade in the Cat, Journal of Neurophysiology, 87, 3, (1252), (2002).
- George R Breese, Darin J Knapp and Sheryl S Moy, Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness, Neuroscience & Biobehavioral Reviews, 26, 4, (441), (2002).
- Frederic Camu and Caroline Vanlersberghe, Pharmacology of systemic analgesics, Best Practice & Research Clinical Anaesthesiology, 16, 4, (475), (2002).
- L. E. Nelson, T. Z. Guo, J. Lu, C. B. Saper, N. P. Franks and M. Maze, The sedative component of anesthesia is mediated by GABAA receptors in an endogenous sleep pathway, Nature Neuroscience, 5, 10, (979), (2002).
- Bruce Jenkins, Yin-Ching Chen and Joseph Mandeville, Pharmacologic Magnetic Resonance Imaging (phMRI), Biomedical Imaging in Experimental Neuroscience, 10.1201/9781420042153.ch6, (153-231), (2009).
- Eva M. Tsapakis and Michael J. Travis, Glutamate and psychiatric disorders, Advances in Psychiatric Treatment, 8, 03, (189), (2002).
- D. Ma, S. Wilhelm, M. Maze and N. P. Franks, Neuroprotective and neurotoxic properties of the 'inert' gas, xenon, British Journal of Anaesthesia, 89, 5, (739), (2002).
- S. Hofman, J. Azérad and Y. Boucher, Effects of Excitatory Amino Acid Receptor Antagonists on Pulpal Blood Flow of the Rat Mandibular Incisor, Journal of Dental Research, 81, 4, (253), (2002).
- Keiji Tabuchi, Zenya Ito, Shigeki Tsuji, Akira Hara, Tetsuro Wada and Jun Kusakari, Effect of Ketamine, Dextromethorphan, and MK-801 on Cochlear Dysfunction Induced by Transient Ischemia, Annals of Otology, Rhinology & Laryngology, 111, 1, (44), (2002).
- C.D. Richards, Anaesthetic modulation of synaptic transmission in the mammalian CNS, British Journal of Anaesthesia, 89, 1, (79), (2002).
- Neil L. Harrison, General anesthesia research: aroused from a deep sleep?, Nature Neuroscience, 5, 10, (928), (2002).
- Shinichi Nakao, Etsuko Miyamoto, Munehiro Masuzawa, Tomoko Kambara and Koh Shingu, Ketamine-induced c-Fos expression in the mouse posterior cingulate and retrosplenial cortices is mediated not only via NMDA receptors but also via sigma receptors, Brain Research, 926, 1-2, (191), (2002).
- Kristen M Coates and Pamela Flood, Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant α7 and α4β2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes, British Journal of Pharmacology, 134, 4, (871-879), (2009).
- Toril Rabben and Ivar Øye, Interindividual differences in the analgesic response to ketamine in chronic orofacial pain, European Journal of Pain, 5, 3, (233-240), (2012).
- Satoshi Shuto, Kiyonori Yoshii and Akira Matsuda, (1S,2R)-1-Pheny1-2-[(S)-1-aminopropy1]-N,N-diethylcyclopropane-carboxamide (PPDC), a New Class of NMDA-Receptor Antagonist: Molecular Design by a Novel Conformational Restriction Strategy., The Japanese Journal of Pharmacology, 85, 3, (207), (2001).
- Jeremy D. Coplan, Sanjay J. Mathew, Eric L.P. Smith, Ronald C. Trost, Bruce A. Scharf, Jose Martinez, Jack M. Gorman, James A. Monn, Darryle D. Schoepp and Leonard A. Rosenblum, Effects of LY354740, a Novel Glutamatergic Metabotropic Agonist, on Nonhuman Primate Hypothalamic-Pituitary-Adrenal Axis and Noradrenergic Function. , CNS Spectrums, 6, 07, (607), (2001).
- Robert Schwarcz, Arash Rassoulpour, Hui-Qiu Wu, Deborah Medoff, Carol A Tamminga and Rosalinda C Roberts, Increased cortical kynurenate content in schizophrenia, Biological Psychiatry, 50, 7, (521), (2001).
- Adrienne C Lahti, Dale Warfel, Tamara Michaelidis, Martin A Weiler, Kristin Frey and Carol A Tamminga, Long-term outcome of patients who receive ketamine during research, Biological Psychiatry, 49, 10, (869), (2001).
- Anil Agarwal, Prabhat Kumar Sinha, Chandra Mani Pandey, Atul Gaur, Chandra Kant Pandey and Soma Kaushik, Effect of a Subanesthetic Dose of Intravenous Ketamine and/or Local Anesthetic Infiltration on Hemodynamic Responses to Skull-Pin Placement, Journal of Neurosurgical Anesthesiology, 13, 3, (189), (2001).
- C Wang, J McInnis, M Ross-Sanchez, P Shinnick-Gallagher, J.L Wiley and K.M Johnson, Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia, Neuroscience, 107, 4, (535), (2001).
- Franz X Vollenweider and Mark A Geyer, A systems model of altered consciousness: integrating natural and drug-induced psychoses, Brain Research Bulletin, 56, 5, (495), (2001).
- Emine Babar, Tuncay Özgünen, Enver Melik, Sait Polat and Hasan Akman, Effects of ketamine on different types of anxiety/fear and related memory in rats with lesions of the median raphe nucleus, European Journal of Pharmacology, 431, 3, (315), (2001).
- David Jane, Pharmacology of NMDA receptors, Glutamate and GABA Receptors and Transporters, 10.1201/9780203299388.ch4, (69-98), (2010).
- Martin Proescholdt, Axel Heimann and Oliver Kempski, Neuroprotection of S(+) ketamine isomer in global forebrain ischemia, Brain Research, 904, 2, (245), (2001).
- Jim Vandergriff, Keith Huff, Ann Bond and David Lodge, Potentiation of responses to AMPA on central neurones by LY392098 and LY404187 in vivo, Neuropharmacology, 40, 8, (1003), (2001).
- Ren-Zhi Zhan, Sihua Qi, Chaoran Wu, Hideyoshi Fujihara, Kiichiro Taga and Koki Shimoji, Intravenous anesthetics differentially reduce neurotransmission damage caused by oxygen-glucose deprivation in rat hippocampal slices in correlation with N-methyl-d-aspartate receptor inhibition, Critical Care Medicine, 29, 4, (808), (2001).
- H J Little, A Clark and W P Watson, Investigations into pharmacological antagonism of general anaesthesia, British Journal of Pharmacology, 129, 8, (1755-1763), (2009).
- John H. Krystal, Alexandre Bennett, Danielle Abi-Saab, Aysenil Belger, Laurence P. Karper, D.Cyril D’Souza, Deborah Lipschitz, Anissa Abi-Dargham and Dennis S. Charney, Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions, Biological Psychiatry, 47, 2, (137), (2000).
- Ross D MacPherson, The pharmacological basis of contemporary pain management, Pharmacology & Therapeutics, 88, 2, (163), (2000).
- Kim Fisher, Terence J Coderre and Neil A Hagen, Targeting the N-Methyl-d-Aspartate Receptor for Chronic Pain Management, Journal of Pain and Symptom Management, 20, 5, (358), (2000).
- M. Dzoljic, On the search for the mechanism of anaesthetic action, Current Anaesthesia & Critical Care, 11, 3, (133), (2000).
- Sarah M Turgeon, Eliza A Auerbach, Megan K Duncan-Smith, Jonathan R George and William W Graves, The Delayed Effects of DTG and MK-801 on Latent Inhibition in a Conditioned Taste-Aversion Paradigm, Pharmacology Biochemistry and Behavior, 66, 3, (533), (2000).
- Suzanne White, Update on the Clinical Treatment of Carbon Monoxide Poisoning, Carbon Monoxide Toxicity, 10.1201/9781420039320.ch11, (261-289), (2010).
- Franz X Vollenweider, Peter Vontobel, Ivar Øye, Daniel Hell and Klaus L Leenders, Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans, Journal of Psychiatric Research, 34, 1, (35), (2000).
- Robert Gerlai and Alexander McNamara, Anesthesia induced retrograde amnesia is ameliorated by ephrinA5-IgG in mice: EphA receptor tyrosine kinases are involved in mammalian memory, Behavioural Brain Research, 108, 2, (133), (2000).
- C.H. Parsons and L.J. Rogers, NMDA receptor antagonists extend the sensitive period for imprinting, Physiology & Behavior, 68, 5, (749), (2000).
- Wolfram Reeker, Christian Werner, Oliver Möllenberg, Lars Mielke and Eberhard Kochs, High-dose S(+)- ketamine improves neurological outcome following incomplete cerebral ischemia in rats, Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 47, 6, (572), (2000).
- Adam Doble, The Role of Excitotoxicity in Neurodegenerative Disease, Pharmacology & Therapeutics, 81, 3, (163), (1999).
- Gary E Duncan, Brian B Sheitman and Jeffery A Lieberman, An integrated view of pathophysiological models of schizophrenia, Brain Research Reviews, 29, 2-3, (250), (1999).
- Evangelia Spandou, George Karkavelas, Vassiliki Soubasi, Persephone Avgovstides-Savvopoulou, Theodoros Loizidis and Olympia Guiba-Tziampiri, Effect of ketamine on hypoxic–ischemic brain damage in newborn rats, Brain Research, 819, 1-2, (1), (1999).
- Christopher F. Spurney, Serapio M. Baca, Angela M. Murray, George E. Jaskiw, Joel E. Kleinman and Thomas M. Hyde, Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats, Synapse, 34, 4, (266-276), (1999).
- K. HASHIMOTO, F. KARASAWA, M. TAODA, Y. UCHIHASHI and T. SATOH, Effects of Epidural Ketamine on Blood Pressure and Renal Sympathetic Nerve Activity in Rabbits, Pharmacy and Pharmacology Communications, 5, 11, (639-643), (2010).
- Viktor L. Arvanov, Xiaofu Liang, Angelo Russo and Rex Y. Wang, LSD and DOB: interaction with 5‐HT2A receptors to inhibit NMDA receptor‐mediated transmission in the rat prefrontal cortex, European Journal of Neuroscience, 11, 9, (3064-3072), (2001).
- H J Faulkner, R D Traub and M A Whittington, Anaesthetic/amnesic agents disrupt beta frequency oscillations associated with potentiation of excitatory synaptic potentials in the rat hippocampal slice, British Journal of Pharmacology, 128, 8, (1813-1825), (2009).
- Megumi Shimoyama, Naohito Shimoyama, Laurel A. Gorman, Kathryn J. Elliott and Charles E. Inturrisi, Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine, Pain, 81, 1, (85), (1999).
- S.J.A Lokwan, P.G Overton, M.S Berry and D Clark, Stimulation of the pedunculopontine tegmental nucleus in the rat produces burst firing in A9 dopaminergic neurons, Neuroscience, 92, 1, (245), (1999).
- Marie-Laure Goubillon, Paul H Strutton, Kevin T O'Byrne, Jean-Christophe Thalabard and Clive W Coen, Ketamine-induced general anesthesia is compatible with gonadotrophin-releasing hormone pulse generator activity in gonadectomized rats: prospects for detailed electrophysiological studies in vivo, Brain Research, 841, 1-2, (197), (1999).
- S.M Turgeon and J.K Roche, The delayed effects of phencyclidine enhance amphetamine-induced behavior and striatal c-Fos expression in the rat, Neuroscience, 91, 4, (1265), (1999).
- Xiaojuan Xu and Edward F Domino, A Further Study on Asymmetric Cross-Sensitization Between MK-801 and Phencyclidine-Induced Ambulatory Activity, Pharmacology Biochemistry and Behavior, 63, 3, (413), (1999).
- Wen Huang and Richard K. Simpson, Ketamine suppresses c-fos expression in dorsal horn neurons after acute constrictive sciatic nerve injury in the rat, Neuroscience Letters, 269, 3, (165), (1999).
- A. Doble, Les récepteurs des acides aminés excitateurs: Aspects pharmacologiques et perspectives dans le traitement de la douleur, Douleur et Analgésie, 12, 3, (175), (1999).
- J. M. Khanna, G. S. Morato and Vania M. M. Ferreira, NMDA Antagonists and Tolerance to Drugs Affecting the Central Nervous System, CNS Drug Reviews, 5, 2, (165-176), (2006).
- Darryle D. Schoepp, James A. Monn, Gerard J. Marek, George A Ghajanian and Bita Moghaddam, LY3 54740: A Systemically Active mGlu2/mGlu3 Receptor Agonist, CNS Drug Reviews, 5, 1, (1-12), (2006).
- Michele D'Amico, Clara Di Filippo, Francesca Rossi and Francesco Rossi, Arrhythmias induced by myocardial ischaemia-reperfusion are sensitive to ionotropic excitatory amino acid receptor antagonists, European Journal of Pharmacology, 366, 2-3, (167), (1999).
- Diego P. C. Beltrutti, Anna C. Trompeo and Salvatore Di Santo, The epidural and intrathecal administration of ketamine, Current Review of Pain, 3, 6, (458), (1999).
- Taleen Hanania, Gilbert R. Hillman and Kenneth M. Johnson, Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit, Synapse, 31, 3, (229-239), (1999).
- Yasuo Katayama, Takaharu Fukuchi, Ann McKee and Akiro Terashi, Effect of nicardipine, a Ca2+ channel blocker, on pyruvate dehydrogenase activity and energy metabolites during cerebral ischemia and reperfusion in gerbil brain, Brain Research, 781, 1-2, (212), (1998).
- H J Faulkner, R D Traub and M A Whittington, Disruption of synchronous gamma oscillations in the rat hippocampal slice: A common mechanism of anaesthetic drug action, British Journal of Pharmacology, 125, 3, (483-492), (2009).
- Robert W. Peoples and Forrest F. Weight, Inhibition of excitatory amino acid‐activated currents by trichloroethanol and trifluoroethanol in mouse hippocampal neurones, British Journal of Pharmacology, 124, 6, (1159-1164), (2009).
- T. Sato, K. Hirota, A. Matsuki, E. K. Zsigmond and S. F. Rabito, Ketamine inhibits the tonic response to carbachol and histamine in the guinea pig trachea, European Journal of Anaesthesiology, 15, 4, (486), (1998).
- Michael J O'Neill, Ann Bond, Paul L Ornstein, Mark A Ward, Caroline A Hicks, Ken Hoo, David Bleakman and David Lodge, Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia, Neuropharmacology, 37, 10-11, (1211), (1998).
- J.‐X. Hao, B. H. Sjölund and Z. Wiesenfeld‐Hallin, Electrophysiological evidence for an antinociceptive effect of ketamine in the rat spinal cord, Acta Anaesthesiologica Scandinavica, 42, 4, (435-441), (2008).
- P Max Headley, Nick Hartell, Boris Chizh and Juan Herrero, Electrophysiology of Spinal Sensory Processing in the Absence and Presence of Surgery and Anesthesia, Handbook of Behavioral State Control, 10.1201/9780849331510.ch30, (2013).
- Robert A Mueller and Rick Hunt, Antagonism of Ketamine-Induced Anesthesia by an Inhibitor of Nitric Oxide Synthesis: A Pharmacokinetic Explanation, Pharmacology Biochemistry and Behavior, 60, 1, (15), (1998).
- Denis Paré, Eric Shink, Hélène Gaudreau, Alain Destexhe and Eric J. Lang, Impact of Spontaneous Synaptic Activity on the Resting Properties of Cat Neocortical Pyramidal Neurons In Vivo, Journal of Neurophysiology, 79, 3, (1450), (1998).
- Masanori Yamauchi, Keiichi Omote and Takafumi Ninomiya, Direct evidence for the role of nitric oxide on the glutamate-induced neuronal death in cultured cortical neurons, Brain Research, 780, 2, (253), (1998).
- M Bergenheim, A.G Crenshaw, J Pedersen and H Johansson, The information transmitted by ensembles of primary spindle afferents is diminished when ketamine is used as a pre-anaesthetic, Neuroscience Research, 30, 2, (177), (1998).
- MICHIO TORU, Biological research on schizophrenia, Psychiatry and Clinical Neurosciences, 52, S6, (S170-S172), (2014).
- Gary E Duncan, Sheryl S Moy, Darin J Knapp, Robert A Mueller and George R Breese, Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia, Brain Research, 787, 2, (181), (1998).
- Per Kristian Eide and Audun Stubhaug, Relief of Glossopharyngeal Neuralgia by Ketamine-induced /V-Methyl-aspartate Receptor Blockade, Neurosurgery, 41, 2, (505), (1997).
- Paul L Wood and Jon E Hawkinson, N-methyl-D-aspartate antagonists for stroke and head trauma, Expert Opinion on Investigational Drugs, 6, 4, (389), (1997).
- T. J. DOHERTY, D. R. GEISER and B. W. ROHRBACH, Effect of high volume epidural morphine, ketamine and butorphanol on halothane minimum alveolar concentration in ponies, Equine Veterinary Journal, 29, 5, (370-373), (2010).
- A. STUBHAUG and H. BREIVIK, Longterm treatment of chronic neuropathic pain with the NMDA (N‐methyl‐D‐aspartate) receptor antagonist ketamine, Acta Anaesthesiologica Scandinavica, 41, 3, (329-331), (2008).
- A. STUBHAUG, H. BREIVIK, P. K. EIDE, M. KREUNEN and A. Foss, Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery, Acta Anaesthesiologica Scandinavica, 41, 9, (1124-1132), (2008).
- F.X Vollenweider, K.L Leenders, C Scharfetter, A Antonini, P Maguire, J Missimer and J Angst, Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG), European Neuropsychopharmacology, 7, 1, (9), (1997).
- Akira Osada, Yoshihisa Fujino, Jun Chen and Natsu Koyama, Differential effects of ketamine and MK-801 on A-fiber and C-fiber responses of spinal wide dynamic range neurons in the cat, Journal of Anesthesia, 11, 3, (184), (1997).
- S. F. Myers, H. H. Salem and J. A. Kaltenbach, Efferent Neurons and Vestibular Cross Talk in the Frog, Journal of Neurophysiology, 77, 4, (2061), (1997).
- Roger Griffiths, Chapter 6 Excitatory amino acid receptors, Molecular and Cellular Pharmacology, 10.1016/S1569-2582(97)80068-2, (111-131), (1997).
- F.X. Vollenweider, K.L. Leenders, I. Øye, D. Hell and J. Angst, Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET), European Neuropsychopharmacology, 7, 1, (25), (1997).
- Toshiyuki Tonohiro, Tsugio Kaneko, Mitsuo Tanabe and Nobuyoshi Iwata, Picolinic acid and indole-2-carboxylic acid: two types of glycinergic compounds modulate motor function differentially, General Pharmacology: The Vascular System, 28, 4, (555), (1997).
- Kevin A. Davis and Herbert F. Voigt, Evidence of Stimulus-Dependent Correlated Activity in the Dorsal Cochlear Nucleus of Decerebrate Gerbils, Journal of Neurophysiology, 78, 1, (229), (1997).
- , References, Excitatory Amino Acids, 10.1016/B978-012546820-6/50015-3, (129-152), (1997).
- Meike Wiedemann and Wolfgang Hanke, The chicken retina as an experimental model for investigation of central nervous lesions, Neuroscience Letters, 232, 2, (99), (1997).
- Beverley Orser, David Smith, Sarah Henderson and Adrian Gelb, Magnesium deficiency increases ketamine sensitivity in rats, Canadian Journal of Anaesthesia, 44, 8, (883), (1997).
- Christopher C. Toner and Jonathan A. Stamford, 8 General anaesthetics as neuroprotective agents, Baillière's Clinical Anaesthesiology, 10, 3, (515), (1996).
- Nick A Hartell and P.Max Headley, NMDA-receptor contribution to spinal nociceptive reflexes: influence of stimulus parameters and of preparatory surgery, Neuropharmacology, 35, 11, (1567), (1996).
- Preston E. Garraghty and Naser Muja, NMDA receptors and plasticity in adult primate somatosensory cortex, Journal of Comparative Neurology, 367, 2, (319-326), (1998).
- David Lodge and Ann Bond, Spinal glutamate receptors, Perspectives in Receptor Research, Proceeding of the 10th Camerino-Noordwijkerhout Symposuim, 10.1016/S0165-7208(96)80020-1, (241-252), (1996).
- Richard F. McLean, Andrew J. Baker, Scott E. Walker, C. David Mazer, Bill I. Wong and Ellen M. Harrington, Ketamine concentrations during cardiopulmonary bypass, Canadian Journal of Anaesthesia, 43, 6, (580), (1996).
- DAVID LODGE, ANN BOND, MICHAEL J O'NEILL, CAROLINE A HICKS and MARTYN G JONES, Stereoselective Effects of 2,3-benzodiazepines In Vivo : Electrophysiology and Neuroprotection Studies, Neuropharmacology, 35, 12, (1681), (1996).
- Uwe Pschorn and Adrian J. Carter, The influence of repeated doses, route and time of administration on the neuroprotective effects of BIII 277 CL in a rat model of focal cerebral ischemia, Journal of Stroke and Cerebrovascular Diseases, 6, 2, (93), (1996).
- G Langelaar, O R Leeuwenkamp, L GW Sterkman, M Torreman and J M Keppel Hesselink, The Effect of Nimodipine Monotherapy and Combined Treatment with Ketamine and Lignocaine in Aneurysmal Subarachnoid Haemorrhage, Journal of International Medical Research, 24, 5, (425), (1996).
- Rafiq Waziri, Glycine therapy of schizophrenia: some caveats, Biological Psychiatry, 39, 3, (155), (1996).
- Toshihito Suzuki, Toshifumi Yamamoto, Takafumi Hori, Atsuomi Baba, Hiroyasu Shiraishi, Takehiko Ito, John E. Piletz and Ing Kang Ho, Autoradiographic study on the pharmacological characteristics of [3H]3-OH-PCP binding sites in rat brain, European Journal of Pharmacology, 310, 2-3, (243), (1996).
- Kent K. Babcock, Xingyu Chen, Katy T. Eggeman, Keshava N. Kumar, Charles J. Decedue and Elias K. Michaelis, A synaptic membrane glycine-, glutamate- and thienylcyclohexylpiperidine-binding protein: isolation and immunochemical characterization, Neurochemistry International, 29, 5, (507), (1996).
- Michaela Scheller, Johannes Bufler, Iris Hertle, Hans J. Schneck, Christian Franke and Eberhard Kochs, Ketamine Blocks Currents Through Mammalian Nicotinic Acetylcholine Receptor Channels by Interaction with Both the Open and the Closed State, Anesthesia & Analgesia, 83, 4, (830), (1996).
- Carlos Hermenegildo, Goizane Marcaida, Carmina Montoliu, Santiago Grisolía, María-Dolores Miñana and Vicente Felipo, NMDA Receptor antagonists prevent acute ammonia toxicity in mice, Neurochemical Research, 21, 10, (1237), (1996).
- Hilary J. Little, How has molecular pharmacology contributed to our understanding of the mechanism(s) of general anesthesia?, Pharmacology & Therapeutics, 69, 1, (37), (1996).
- Laurent Monassier, Eduardo Tibiriça, Jean-Christophe Roegel, Josiane Feldman and Pascal Bousquet, MK-801 and memantine inhibit a centrally induced increase in myocardial oxygen demand in rabbits, European Journal of Pharmacology, 305, 1-3, (109), (1996).
- Sabine Himmelseher, Ernst Pfenninger and Michael Georgieff, The Effects of Ketamine-Isomers on Neuronal Injury and Regeneration in Rat Hippocampal Neurons, Anesthesia & Analgesia, 83, 3, (505), (1996).
- Boris A. Chizh and P. Max Headley, Thyrotropin-releasing hormone facilitates spinal nociceptive responses by potentiating NMDA receptor-mediated transmission, European Journal of Pharmacology, 300, 3, (183), (1996).
- T. Morita, S. Hitomi, S. Saito, T. Fujita, Y. Uchihashi and H. Kuribara, Repeated ketamine administration produces up-regulation of muscarinic acetylcholine receptors in the forebrain, and reduces behavioral sensitivity to scopolamine in mice, Psychopharmacology, 117, 4, (396), (1995).
- G.J. Lees, Influence of ketamine on the neuronal death caused by NMDA in the rat hippocampus, Neuropharmacology, 34, 4, (411), (1995).
- S. Farkas and H. Ono, Participation of NMDA and non‐NMDA excitatory amino acid receptors in the mediation of spinal reflex potentials in rats: an in vivo study, British Journal of Pharmacology, 114, 6, (1193-1205), (2012).
- Adrian J. Carter, Antagonists of the NMDA receptor-channel complex and motor coordination, Life Sciences, 57, 10, (917), (1995).
- Jacek Luczak, Anthony H. Dickenson and Aleksandra Kotlinska-Lemieszek, The Role of Ketamine, an NMDA Receptor Antagonist, in the Management of Pain, Progress in Palliative Care, 3, 4, (127), (1995).
- H. Tegtmeyer-Metzdorf, B. Roth, M. Günther, M. Theisohn, U. Heinemann, H. A. Adams and G. Sticht, Ketamine and strychnine treatment of an infant with nonketotic hyperglycinaemia, European Journal of Pediatrics, 154, 8, (649), (1995).
- M. L. Carlsson, The selective 5-HT2a receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse ? implications for psychosis, Journal of Neural Transmission, 100, 3, (225), (1995).
- Sylvain Pirot, Jacques Glowinski and Anne-Marie Thierry, Excitatory responses evoked in prefrontal cortex by mediodorsal thalamic nucleus stimulation: influence of anaesthesia, European Journal of Pharmacology, 285, 1, (45), (1995).
- P. Popoli, R. Reggio, A. Pèzzola and A. Scotti de Carolis, The stimulation of cholecystokinin receptors in the rostral nucleus accumbens significantly antagonizes the EEG and behavioural effects induced by phencyclidine in rats, Psychopharmacology, 120, 2, (156), (1995).
- Per Kristian Eide, Audun Stubhaug and Ivar Øye, 8 The NMDA-antagonist ketamine for prevention and treatment of acute and chronic post-operative pain, Baillière's Clinical Anaesthesiology, 9, 3, (539), (1995).
- C. McFarlane, D.S. Warner and F. Dexter, Interactions between NMDA and AMPA glutamate receptor antagonists during halothane anesthesia in the rat, Neuropharmacology, 34, 6, (659), (1995).
- J. Barker and R.A. Duckworth, Ketamine and the cerebral circulation, Anaesthesia, 50, 8, (751-752), (2007).
- Narinder Rawal, Spinal Antinociception: Clinical Aspects, Annals of Medicine, 27, 2, (263), (1995).
- S. M. LILLRANK, S. S. OJA and P. SARANSAARI, The effect of phencyclidine on [3H]GABA and [3H]fulnitrazepam binding in the brain of naive and handling‐habituated rats, Acta Physiologica Scandinavica, 153, 1, (33-41), (2008).
- Roland Björkman, Central antinociceptive effects of non‐steroidal anti‐inflammatory drugs and paracetarmol, Acta Anaesthesiologica Scandinavica, 39, s103, (7-44), (2008).
- Yukihiro Noda, Kiyofumi Yamada, Hiroshi Furukawa and Toshitaka Nabeshima, Involvement of nitric oxide in phencyclidine-induced hyperlocomotion in mice, European Journal of Pharmacology, 286, 3, (291), (1995).
- L. Arendt-Nielsen, S. Petersen-Felix, M. Fischer, P. Bak, P. Bjerring and A. M. Zbinden, The Effect of N-Methyl-D-aspartate Antagonist (Ketamine) on Single and Repeated Nociceptive Stimuli, Anesthesia & Analgesia, 81, 1, (63), (1995).
- K.E. Binns and T.E. Salt, Excitatory amino acid receptors modulate habituation of the response to visual stimulation in the cat superior colliculus, Visual Neuroscience, 12, 03, (563), (1995).
- Stefano Sagratella, Nmda antagonists: Antiepileptic-neuroprotective drugs with diversified neuropharmacological profiles, Pharmacological Research, 32, 1-2, (1), (1995).
- Leon G.J.E. Reijmers, Patrick M.L. Vanderheyden and Bernard W.M.M. Peeters, Changes in prepulse inhibition after local administration of NMDA receptor ligands in the core region of the rat nucleus accumbens, European Journal of Pharmacology, 272, 2-3, (131), (1995).
- Toshihito Suzuki, Toshifumi Yamamoto, Takafumi Hori, Shuzo Abe, Takashi Moroji, Hiroyasu Shiraishi, Takehiko Ito and Ing Kang Ho, Quantitative autoradiographic localization of [3H]3-OH-PCP (1-(1(3-Hydroxyphenyl)cyclohexyl)piperidine) binding sites in rat brain, Brain Research Bulletin, 37, 4, (431), (1995).
- H. kubová and P. Mares̆, Suppression of cortical epileptic afterdischarges by ketamine is not stable during ontogenesis in rats, Pharmacology Biochemistry and Behavior, 52, 3, (489), (1995).
- A. Bond and D. Lodge, Pharmacology of metabotropic glutamate receptor-mediated enhancement of responses to excitatory and inhibitory amino acids on rat spinal neurones in vivo, Neuropharmacology, 34, 8, (1015), (1995).
- M.D. Tricklebank, L.J. Bristow, P.H. Hutson, P.D. Leeson, M. Rowley, K. Saywell, L. Singh, F.D. Tattersall, L. Thorn and B.J. Williams, The anticonvulsant and behavioural profile of L‐687,414, a partial agonist acting at the glycine modulatory site on the N‐methyl‐D‐aspartate (NMDA) receptor complex, British Journal of Pharmacology, 113, 3, (729-736), (2012).
- Hisao Komatsu, Junko Nogaya, Masaaki Ueki, Satoshi Yokono and Kenji Ogli, POSSIBLE PARTICIPATION OF NMDA AND GLYCINE RECEPTORS BUT NOT GABAA RECEPTORS IN ENFLURANE‐INDUCED OPISTHOTONUS IN MICE, Clinical and Experimental Pharmacology and Physiology, 21, 6, (495-499), (2007).
- A. O'Connell, B. Earley and B.E. Leonard, Phencyclidine prevents spatial navigation and passive avoidance deficits in ibotenate lesioned rats, Neuropharmacology, 33, 9, (1095), (1994).
- Romana Mikolášová, Libor Velíšek, Jaroslav Vorlíček and Pavel Mareš, Developmental changes of ketamine action against epileptic afterdischarges induced by hippocampal stimulation in rats, Developmental Brain Research, 81, 1, (105), (1994).
- Ethan D. Cohen and Robert F. Miller, The role of NMDA and non-NMDA excitatory amino acid receptors in the functional organization of primate retinal ganglion cells, Visual Neuroscience, 11, 02, (317), (1994).
- Philippe Mettens, Guy Cheron and Emile Godaux, Effect of Ketamine on the Oculomotor Neural Integrator and on the Velocity Storage Element, Visual and Oculomotor Functions - Advances in Eye Movement Research, 10.1016/B978-0-444-81808-9.50031-7, (295-313), (1994).
- Rui Tao and Sidney B. Auerbach, Anesthetics block morphine‐induced increases in serotonin release in rat CNS, Synapse, 18, 4, (307-314), (2004).
- M.L. Semos and P.M. Headley, The role of nitric oxide in spinal nociceptive reflexes in rats with neurogenic and non-neurogenic peripheral inflammation, Neuropharmacology, 33, 11, (1487), (1994).
- Donald D. Price, Jianren Mao, Hanan Frenk and David J. Mayer, The Symbol receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man, Pain, 59, 2, (165), (1994).
- Xue-Min Gao and Carol A. Tamminga, An increase in NMDA-sensitive [3H]glutamate and [3H]kainate binding in hippocampus 24 hours after PCP, Neuroscience Letters, 174, 2, (149), (1994).
- Yoshitaka Uchihashi, Hisashi Kuribara, Yukitaka Isa, Toshihiro Morita and Tetsuo Sato, The disruptive effects of ketamine on passive avoidance learning in mice: involvement of dopaminergic mechanism, Psychopharmacology, 116, 1, (40), (1994).
- G. CHERON, P. METTENS, E. GODAUX and M. ESCUDERO, Effects of the APV Injection into the Abducens and the Prepositus Hypoglossi Nuclei on the Generation of Eye Position Signal, Information Processing Underlying Gaze Control, 10.1016/B978-0-08-042506-1.50007-2, (21-29), (1994).
- J.-Y. Koh and D.W. Choi, Zinc toxicity on cultured cortical neurons: Involvement of N-methyl-d-aspartate receptors, Neuroscience, 60, 4, (1049), (1994).
- P. Popoli, A. Pèzzola and S. Sagratella, Diphenylhydantoin potentiates the EEG and behavioural effects induced by N-methyl-D-aspartate antagonists in rats, Psychopharmacology, 113, 3-4, (471), (1994).
- Laurent Monassier, Eduardo Tibiriça, Jean‐Christophe Roegel, Bertrand Mettauer, Josiane Feldman and Pascal Bousquet, Prevention by NMDA receptor antagonists of the centrally‐evoked increases of cardiac inotropic responses in rabbits, British Journal of Pharmacology, 111, 4, (1347-1354), (2012).
- Per Kristian Eide, Ellen Jørum, Audun Stubhaug, Jørn Bremnes and Harald Breivik, Relief of post-herpetic neuralgia with the Symbol receptor antagonist ketamine: A double-blind, cross-over comparison with morphine and placebo, Pain, 58, 3, (347), (1994).
- M.D. Cunningham, J.W. Ferkany and S.J. Enna, Excitatory amino acid receptors: A gallery of new targets for pharmacological intervention, Life Sciences, 54, 3, (135), (1994).
- Juan F. Herrero, P.Max Headley and Chris G. Parsons, Memantine selectively depresses NMDA receptor-mediated responses of rat spinal neurones in vivo, Neuroscience Letters, 165, 1-2, (37), (1994).
- Michio Toru, Akeo Kurumaji and Masahiko Ishimaru, Excitatory amino acids: Implications for psychiatric disorders research, Life Sciences, 55, 22, (1683), (1994).
- B.A. Chizh and P.M. Headley, Thyrotropin-releasing hormone (TRH)-induced facilitation of spinal neurotransmission: A role for NMDA receptors, Neuropharmacology, 33, 1, (115), (1994).
- William D. Wessinger, Tolerance to and dependence on MK-801 (dizocilpine) in rats, Pharmacology Biochemistry and Behavior, 49, 4, (1049), (1994).
- Anna Capasso, Amalia Di Giannuario, Alberto Loizzo, Stefano Pieretti and Ludovico Sorrentino, Phencyclidine reduces inherited neocortical spindling in DBA/2J mice, Life Sciences, 54, 15, (PL235), (1994).
- József I. Székely, Lawrence G. Sharpe and Jonathan L. Katz, Effects of caramiphen and phencyclidine alone and in combination on behavior in the rat, Pharmacology Biochemistry and Behavior, 47, 3, (709), (1994).
- Louis Trevisan, Lawrence W. Fitzgerald, Nils Brose, Gregory P. Gasic, Stephen F. Heinemann, Ronald S. Duman and Eric J. Nestler, Rapid Communication Chronic Ingestion of Ethanol Up‐Regulates NMDAR1 Receptor Subunit Immunoreactivity in Rat Hippocampus, Journal of Neurochemistry, 62, 4, (1635-1638), (2008).
- Wojciech Danysz, Ursula Essmann, Iris Bresink and Rolf Wilk, Glutamate antagonists have different effects on spontaneous locomotor activity in rats, Pharmacology Biochemistry and Behavior, 48, 1, (111), (1994).
- P.S. Palombi, P.M. Backoff and D.M. Caspary, Paired tone facilitation in dorsal cochlear nucleus neurons: A short-term potentiation model testable in vivo, Hearing Research, 75, 1-2, (175), (1994).
- Xiaojuan Xu and Edward F. Domino, Asymmetric cross-sensitization to the locomotor stimulant effects of phencyclidine and MK-801, Neurochemistry International, 25, 2, (155), (1994).
- Christopher S. Colwell, Claire M. Kaufman, Michael Menaker and Martin R. Ralph, Light-Induced Phase Shifts and Fos Expression in the Hamster Circadian System: The Effects of Anesthetics, Journal of Biological Rhythms, 8, 3, (179), (1993).
- Marc-Williams Debono, Joëlle Le Guern, Thierry Canton, Adam Doble and Laurent Pradier, Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes, European Journal of Pharmacology, 235, 2-3, (283), (1993).
- O. ShibataM.D., T. Makita, A. Nagatani, T. Fujigaki, H. Nakamura, M. Fukusaki and K. Sumikawa, Combined effects of adrenergic and intravenous anesthetic agents on inositol monophosphate levels in rat liver prisms, Acta Anaesthesiologica Scandinavica, 37, 3, (303-306), (2008).
- Sunita Rajdev and Ian J. Reynolds, Effects of pH on the actions of dizocilpine at the N‐methyl‐D‐aspartate receptor complex, British Journal of Pharmacology, 109, 1, (107-112), (2012).
- Nina T Gentile and Tracy K McIntosh, Antagonists of excitatory amino acids and endogenous opioid peptides in the treatment of experimental central nervous system injury, Annals of Emergency Medicine, 22, 6, (1028), (1993).
- Shin-ichi Nakao, Toshiyuki Arai, Kenjiro Mori, Osamu Yasuhara, Ikuo Tooyama and Hiroshi Kimura, High-dose ketamine does not induce c-Fos protein expression in rat hippocampus, Neuroscience Letters, 151, 1, (33), (1993).
- Pirjo Saransaari and Simo S. Oja, Phencyclidine-binding sites in mouse cerebral cortex during development and ageing: effects of inhibitory amino acids, Mechanisms of Ageing and Development, 68, 1-3, (125), (1993).
- Keith Williams, Shari L. Russell, Yu Min Shen and Perry B. Molinoff, Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro, Neuron, 10, 2, (267), (1993).
- Alice A. Larson and Xiaofeng Sun, Regulation of sigma activity by the amino-terminus of substance P in the mouse spinal cord: Involvement of phencyclidine (PCP) sites not linked to N-methyl-d-aspartate (NMDA) activity, Neuropharmacology, 32, 9, (909), (1993).
- Jacques Na¨sstro¨m, Urban Karlsson and Odd-Geir Berge, Systemic or intracerebroventricular injection of NMDA receptor antagonists attenuates the antinociceptive activity of intrathecally administered NMDA receptor antagonists, Brain Research, 623, 1, (47), (1993).
- Tsukasa Sakurada, Kazushige Katsumata, Yoichi Manome, Koichi Tan-No, Shinobu Sakurada, Kensuke Kisara and Masataka Ohba, Antinociceptive effects in the formalin and capsaicin tests after intrathecal administration of substance P analogues in mice, European Journal of Pharmacology, 242, 1, (47), (1993).
- William A. Carlezon and Roy A. Wise, Phencyclidine-induced potentiation of brain stimulation reward: acute effects are not altered by repeated administration, Psychopharmacology, 111, 4, (402), (1993).
- X. Sun and A.A. Larson, MK-801 and phencyclidine act at phencyclidine sites that are not linked to N-methyl-d-aspartate activity to inhibit behavioral sensitization to kainate, Neuroscience, 54, 3, (773), (1993).
- Kiyoshi Matsuno, Toshihiko Senda and Shiro Mita, Correlation between potentiation of neurogenic twitch contraction and benzomorphan σ receptor binding potency in the mouse vas deferens, European Journal of Pharmacology, 231, 3, (451), (1993).
- Ting Wang and Edward D. French, Effects of phencyclidine on spontaneous and excitatory amino acid-induced activity of ventral tegmental dopamine neurons: An extracellular in vitro study, Life Sciences, 53, 1, (49), (1993).
- L. Velíšek, R. Vondřičková and P. Mareš, Models of simple partial and absence seizures in freely moving rats: Action of ketamine, Pharmacology Biochemistry and Behavior, 45, 4, (889), (1993).
- Sharin Y. Sakurai, John B. Penney and Anne B. Young, Regionally Distinct N‐Methyl‐D‐Aspartate Receptors Distinguished by Quantitative Autoradiography of [3H]MK‐801 Binding in Rat Brain, Journal of Neurochemistry, 60, 4, (1344-1353), (2006).
- Anne Marie F. Salapatek and Nicholas E. Diamant, Assessment of neural inhibition of the lower esophageal sphincter in cats with esophagitis, Gastroenterology, 104, 3, (810), (1993).
- Catherine F. Stannard and Gwenda E. Porter, Ketamine hydrochloride in the treatment of phantom limb pain, Pain, 54, 2, (227), (1993).
- Y. Boucher, B. Pollin and J. Azérad, Microinfusions of excitatory amino acid antagonists into the trigeminal sensory complex antagonize the jaw opening reflex in freely moving rats, Brain Research, 614, 1-2, (155), (1993).
- B. J. Cole, M. Klewer, G. H. Jones and D. N. Stephens, Contrasting effects of the competitive NMDA antagonist CPP and the non-competitive NMDA antagonist MK 801 on performance of an operant delayed matching to position task in rats, Psychopharmacology, 111, 4, (465), (1993).
- Ernesto Fedele, Paola Versace and Maurizio Raiteri, Evaluation of the mechanisms underlying the kainate-induced impairment of [3H]dopamine release in the rat striatum, European Journal of Pharmacology, 249, 1-2, (71), (1993).
- Gary R. Lewin and Stephen B. McMahon, Muscle Afferents Innervating Skin Form Somatotopically Appropriate Connections in the Adult Rat Dorsal Horn, European Journal of Neuroscience, 5, 8, (1083-1092), (2006).
- H. C. LIN, J. C. THURMON, G.J. BENSON and W.J. TRANQUILLI, Review: Telazol – a review of its pharmacology and use in veterinary medicine, Journal of Veterinary Pharmacology and Therapeutics, 16, 4, (383-418), (2008).
- Kyle R. Gee, Graham J. Durant, Darren L. Holmes, Sharad S. Magar, Eckard Weber, Scott T. Wong and John F. W. Keana, N-(3-Azidophenyl)-N-methyl-N'-([4-1H]- and [4-3H]-1-naphthyl)guanidine. A potent and selective ligand designed as a photoaffinity label for the phencyclidine site of the N-methyl-D-aspartate receptor, Bioconjugate Chemistry, 4, 3, (226), (1993).
- Jacques Näsström, Éva Böö, Maria Ståhlberg and Odd-Geir Berge, Tissue distribution of two NMDA receptor antagonists, [3H]CGS 19755 and [3H]MK-801, after intrathecal injection in mice, Pharmacology Biochemistry and Behavior, 44, 1, (9), (1993).
- V. Radhakrishnan and J.L. Henry, Excitatory amino acid receptor mediation of sensory inputs to functionally identified dorsal horn neurons in cat spinal cord, Neuroscience, 55, 2, (531), (1993).
- Hisao Komatsu, Junko Nogaya, Daisuke Anabuki and Kenji Ogli, The N-Methyl-D-aspartate (NMDA) receptor antagonist dizocilpine (MK-801) suppresses enfturane-induced opisthotonus in mice, Journal of Anesthesia, 7, 4, (520), (1993).
- Robert Lalonde and Christian C. Joyal, Effects of ketamine and L-glutamic acid diethyl ester on spatial and nonspatial learning tasks in rats, Pharmacology Biochemistry and Behavior, 44, 3, (539), (1993).
- Anita Verma and S. K. Kulkarni, Modulation of MK-801 response by dopaminergic agents in mice, Psychopharmacology, 107, 2-3, (431), (1992).
- Yanguo Hong and James L. Henry, Glutamate, NMDA and NMDA receptor antagonists: cardiovascular effects of intrathecal administration in the rat, Brain Research, 569, 1, (38), (1992).
- Ian A. Silver and Maria Erecińska, Ion Homeostasis in Rat Brain in vivo: Intra- and Extracellular [Ca2+] and [H+] in the Hippocampus during Recovery from Short-Term, Transient Ischemia, Journal of Cerebral Blood Flow & Metabolism, 12, 5, (759), (1992).
- G.J. Lees, Effects of anaesthetics, anticonvulsants and glutamate antagonists on kainic acid-induced local and distal neuronal loss, Journal of the Neurological Sciences, 108, 2, (221), (1992).
- J. Berg‐Johnsen and I. A. Langmoen, The effect of isoflurane on excitatory synaptic transmission in the rat hippocampus, Acta Anaesthesiologica Scandinavica, 36, 4, (350-355), (2008).
- Joannes T. M. Linders, Brian R. de Costa, Neile A. Grayson and Kenner C. Rice, Synthesis of unlabelled and tritium labelled 4‐isothiocyanato‐1‐(1‐phenylcyclohexyl)piperidine (fourphit), tools for the study of the dopamine reuptake complex., Journal of Labelled Compounds and Radiopharmaceuticals, 31, 9, (671-683), (2006).
- Sunita Rajdev and Ian J. Reynolds, Effects of Monovalent and Divalent Cations on 3‐(+)[125I]Iododizocilpine Binding to the N‐Methyl‐d‐Aspartate Receptor of Rat Brain Membranes, Journal of Neurochemistry, 58, 4, (1469-1476), (2006).
- J. Velíšková and L.S. Velíšek, Picrotoxin-induced tonic-clonic seizures and lethality are decreased by MK-801 in developing rats, Pharmacology Biochemistry and Behavior, 43, 1, (291), (1992).
- Kiyokazu Ogita, Takeo Suzuki, Zuo Pingping and Yukio Yoneda, Inhibition by Calmodulin Antagonists of [3H]MK‐801 Binding in Brain Synaptic Membranes, Journal of Neurochemistry, 59, 3, (1008-1016), (2006).
- C. Molander, J. Hongpaisan and G. Grant, Changing pattern Of C-FOS expression in spinal cord neurons after electrical stimulation of the chronically injured sciatic nerve in the rat, Neuroscience, 50, 1, (223), (1992).
- Haesung Lee and Ben H. Choi, Density and distribution of excitatory amino acid receptors in the developing human fetal brain: A quantitative autoradiographic study, Experimental Neurology, 118, 3, (284), (1992).
- N.G. Bowery, G.W. Price, R. Ransom, E.H.F. Wong, A.E. Fletcher and G.P. Wilkin, Autoradiography and interaction of modulators of NMDA receptor activation, Neurotransmitters in Epilepsy, 10.1016/B978-0-444-89710-7.50029-X, (189-196), (1992).
- K. Harada, T. Yoshimura, K. Nakajima, H. Ito, Y. Ebina and R. Shingai, N-methyl-D-aspartate increases cytosolic Ca2+ via G proteins in cultured hippocampal neurons, American Journal of Physiology-Cell Physiology, 262, 4, (C870), (1992).
- Masahiro Irifune, Takao Shimizu, Masahiro Nomoto and Takeo Fukuda, Ketamine-induced anesthesia involves the N-methyl-d-aspartate receptor-channel complex in mice, Brain Research, 596, 1-2, (1), (1992).
- Riyo Enomoto, Kiyokazu Ogita, Daiken Han and Yukio Yoneda, Differential Modulation by Divalent Cations of [3H]MK‐801 Binding in Brain Synaptic Membranes, Journal of Neurochemistry, 59, 2, (473-481), (2006).
- Yanguo Hong and James L. Henry, NMDA receptor antagonists block cardiovascular responses to intrathecal administration of D-baclofen in the rat, European Journal of Pharmacology, 216, 2, (257), (1992).
- Graham D. Sher, Steven M. Cartmell, Linda Gelgor and Duncan Mitchell, Role of Symbol and opiate receptors in nociception during and after ischaemia in rats, Pain, 49, 2, (241), (1992).
- Richard H.P. Porter, Roger S.J. Briggs and Peter J. Roberts, Modulation of acid ([3H]CPP) binding by ligands acting at the glycine and the polyamine sites of the rat brain NMDA receptor complex, European Journal of Pharmacology: Molecular Pharmacology, 227, 1, (83), (1992).
- A.R. McQuiston and W.F. Colmers, Neuropeptide Y does not alter NMDA conductances in CA3 pyramidal neurons: A slice-patch study, Neuroscience Letters, 138, 2, (261), (1992).
- De Xing Zhang and William B. Levy, Ketamine blocks the induction of LTP at the lateral entorhinal cortex-dentate gyrus synapses, Brain Research, 593, 1, (124), (1992).
- Alister G. Macdonald, R.L. Ramsey, C.J. Shelton and P.N.R. Usherwood, Single channel analysis of ketamine interaction with a quisqualate receptor, European Journal of Pharmacology, 210, 3, (223), (1992).
- Edward D. French, Competitive NMDA receptor antagonists attenuate phencyclidine-induced excitations of A10 dopamine neurons, European Journal of Pharmacology, 217, 1, (1), (1992).
- J. Mantz, Effets des anesthésiques intraveineux sur les neurones du système nerveux central : mécanismes d'action cellulaires et moléculaires, Annales Françaises d'Anesthésie et de Réanimation, 11, 5, (540), (1992).
- N.L. Daló and J.C. Piña-Crespo, Ketamine abolishes the tonic phase of the seizures evoked by sudden cooling of toad isolated spinal cords, Neuropharmacology, 31, 5, (509), (1992).
- S. Sagratella, A. Pezzola, P. Popoli and A. Scotti de Carolis, Different capability ofn-methyl-d-aspartate antagonists to elicit EEG and behavioural phencyclidine-like effects in rats, Psychopharmacology, 109, 3, (277), (1992).
- L.A. Marco and R.S. Joshi, A ketamine-induced rat model of tardive dyskinesia, Progress in Neurobiology, 38, 6, (571), (1992).
- Kiyokazu Ogita, Atsuko Ohkawara, Takeo Suzuki, Takao Ohgaki, Shuji Uchida, Haruo Meguri and Yukio Yoneda, Effects of ifenprodil on the N-methyl-d-aspartate receptor ionophore complex in rat brain, Neurochemistry International, 21, 1, (135), (1992).
- Richard F. Squires and Else Saederup, A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: More support for a continuum hypothesis of ?functional? psychosis, Neurochemical Research, 16, 10, (1099), (1991).
- J. Thomas Cunningham, Margaret J. Sullivan, Gaylen L. Edwards, Roxanna Farinpour, T.G. Beltz and Alan Kim Johnson, Dissociation of experimentally induced drinking behavior by ibotenate injection into the median preoptic nucleus, Brain Research, 554, 1-2, (153), (1991).
- László Vécsei and M.Flint Beal, Comparative behavioral and pharmacological studies with centrally administered kynurenine and kynurenic acid in rats, European Journal of Pharmacology, 196, 3, (239), (1991).
- Hyacinth C. Akunne, Audrey A. Reid, Andrew Thurkauf, Arthur E. Jacobson, Brain de Costa, Kenner C. Rice, Melvyn P. Heyes and Richard B. Rothman, [3H]1‐[2‐(2‐thienyl)cyclohexyl]piperidine labels two high‐affinity binding sites in human cortex: Further evidence for phencyclidine binding sites associated with the biogenic amine reuptake complex, Synapse, 8, 4, (289-300), (2004).
- Takafumi Hori, Toshifumi Yamamoto, Kotaro Hatta and Takashi Moroji, Modulation of Mg2+‐dependent [3H]TCP binding by L‐glutamate, glycine, and guanine nucleotides in rat cerebral cortex, Synapse, 8, 1, (13-21), (2004).
- Mariano Amador and John A. Dani, MK‐801 inhibition of nicotinic acetylcholine receptor channels, Synapse, 7, 3, (207-215), (2004).
- Brian R. de Costa and Mariena V. Mattson, Synthesis and evaluation of [3H]‐4‐fluoro‐1‐[1‐(3‐hydroxyphenyl)cyclohexyl]piperidine, a potential tool for autoradiographic study of the phencyclidine receptor, Journal of Labelled Compounds and Radiopharmaceuticals, 29, 1, (63-74), (2006).
- Ian J. Reynolds and Alan M. Palmer, Regional Variations in [3H]MK801 Binding to Rat Brain N‐Methyl‐D‐Aspartate Receptors, Journal of Neurochemistry, 56, 5, (1731-1740), (2006).
- P.H. Hutson, L.J. Bristow, L. Thorn and M.D. Tricklebank, R‐(+)‐HA‐966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine, British Journal of Pharmacology, 103, 4, (2037-2044), (2012).
- Hans‐Georg Schaible, Blair D. Grubb, Volker Neugebauer and Maria Oppmann, The Effects of NMDA Antagonists on Neuronal Activity in Cat Spinal Cord Evoked by Acute Inflammation in the Knee Joint, European Journal of Neuroscience, 3, 10, (981-991), (2006).
- G. Keilhoff, G. Wolf and F. S˛t˛astný, Effects of MK-801, ketamine and alaptide on quinolinate models in the maturing hippocampus, Neuroscience, 42, 2, (379), (1991).
- S.Y. Sakurai, J.-H.J. Cha, J.B. Penney and A.B. Young, Regional distribution and properties of [3H]MK-801 binding sites determined by quantitative autoradiography in rat brain, Neuroscience, 40, 2, (533), (1991).
- Eric Scarfone, Mats Ulfendahl, Lillian Figueroa and Åke Flock, Anaesthetics may change the shape of isolated type I hair cells, Hearing Research, 54, 2, (247), (1991).
- BORIS TABAKOFF, CAROLYN S. RABE and PAULA L. HOFFMAN, Selective Effects of Sedative/Hypnotic Drugs on Excitatory Amino Acid Receptors in Brain, Annals of the New York Academy of Sciences, 625, 1, (488-495), (2006).
- S. Sagratella, Y.C. Zeng, C. Frank and A. Scotti de Carolis, Diversified electrophysiological properties of morphinan drugs in rats, General Pharmacology: The Vascular System, 22, 2, (231), (1991).
- M.D.C. Simpson, P. Slater, M.C. Royston and J.F.W. Deakin, Alterations in phencyclidine and sigma binding sites in schizophrenic brains, Schizophrenia Research, 6, 1, (41), (1991).
- M. Ouardouz and J. Durand, GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneurones, Neuroscience Letters, 125, 1, (5), (1991).
- N. Hori, N. Doi, S. Miyahara, Y. Shinoda and D.O. Carpenter, Appearance of NMDA receptors triggered by anoxia independent of voltage in vivo and in vitro, Experimental Neurology, 112, 3, (304), (1991).
- John Church, John D. Millar, Martyn G. Jones and David Lodge, NMDA receptor antagonist effects of the stereoisomers of β-cyclazocine in rats, in vivo and in vitro, European Journal of Pharmacology, 192, 3, (337), (1991).
- Mark J. Benvenga, Allison V. Wing and Robert A. Del Vecchio, The discriminative stimulus effect of MK-801 in ketamine-trained rats, Pharmacology Biochemistry and Behavior, 38, 1, (211), (1991).
- Robert S. Fisher, 12. Neuronal damage and epilepsy: basic and clinical interface, Epilepsy Research, 10, 1, (80), (1991).
- Nancy L. Desmond, Costa M. Colbert, De Xing Zhang and William B. Levy, NMDA receptor antagonists block the induction of long-term depression in the hippocampal dentate gyrus of the anesthetized rat, Brain Research, 552, 1, (93), (1991).
- Sylvie A. Malenfant, Stephen O'Hearn and Alison S. Fleming, MK801, an NMDA antagonist, blocks acquisition of a spatial task but does not block maternal experience effects, Physiology & Behavior, 49, 6, (1129), (1991).
- Yukio Yoneda and Kiyokazu Ogita, Neurochemical aspects of the receptor complex, Neuroscience Research, 10, 1, (1), (1991).
- S. Boyce, N.M.J. Rupniak, M.J. Steventon, G. Cook and S.D. Iversen, Psychomotor activity and cognitive disruption attributable to NMDA, but not sigma, interactions in primates, Behavioural Brain Research, 42, 2, (115), (1991).
- F Zenone and JM Kamenka, Conformational adaptation to surroundings of PCP, TCP and BTCP molecules. A tentative explanation for different biochemical specificities, European Journal of Medicinal Chemistry, 26, 7, (677), (1991).
- Jen Hill Lucas and Amy Wolf, In vitro studies of multiple impact injury to mammalian CNS neurons: prevention of perikaryal damage and death by ketamine, Brain Research, 543, 2, (181), (1991).
- Gean Po-Wu and Chang Fang-Chia, Ketamine suppresses synchronized discharges in the disinhibited amygdala slice, Brain Research Bulletin, 26, 6, (923), (1991).
- Ratna Sircar and Stephen R. Zukin, Kinetic mechanisms of glycine requirement for N-methyl-d-aspartate channel activation, Brain Research, 556, 2, (280), (1991).
- Wojciech Danysz, Metaphit fails to antagonize PCP-induced passive avoidance deficit, Pharmacology Biochemistry and Behavior, 38, 1, (231), (1991).
- Luis A. Marco, Rajani S. Joshi and Robert B. Chronister, Effects of MK-801, a non-competitive NMDA antagonist, on linguopharyngeal events in rats, Psychopharmacology, 103, 4, (462), (1991).
- Nick A. Hartell and Max P. Headley, Preparative surgery enhances the direct spinal actions of three injectable anaesthetics in the anaesthetized rat, Pain, 46, 1, (75), (1991).
- H. Koyuncuoǧlu and F. Aricioǧlu, Previous chronic blockade of NMDA receptors intensifies morphine dependence in rats, Pharmacology Biochemistry and Behavior, 39, 3, (575), (1991).
- Tadimeti S. Rao, Patricia C. Contreras, Julie A. Cler, Steve J. Mick, Vickie M. Dilworth, Smriti Iyengar, Joseph B. Monahan and Paul L. Wood, Contrasting Neurochemical Interactions of Tiletamine, a Potent Phencyclidine (PCP) Receptor Ligand, with the N‐Methyl‐D‐Aspartate‐Coupled and ‐Uncoupled PCP Recognition Sites, Journal of Neurochemistry, 56, 3, (890-897), (2006).
- Caroline R. Maciver, Donna L. Bednar and E. William Karbon, Opposite effects of spermine and arcaine on responses of receptors expressed in Xenopus oocytes, Neuroscience Letters, 132, 2, (146), (1991).
- Rachel Haring, Patric K. Stanton, Mark A. Scheideler and Joseph R. Moskal, Glycine‐Like Modulation of N‐Methyl‐d‐Aspartate Receptors by a Monoclonal Antibody That Enhances Long‐Term Potentiation, Journal of Neurochemistry, 57, 1, (323-332), (2006).
- Yukio Yoneda, Kiyokazu Ogita, Riyo Enomoto, Takeo Suzuki and Shozo Kito, Identification and characterization of specific binding sites of [3H]spermidine in synaptic membranes of rat brain, Brain Research, 563, 1-2, (17), (1991).
- Keith Williams, Carmelo Romano, Marc A. Dichter and Perry B. Molinoff, Modulation of the NMDA receptor by polyamines, Life Sciences, 48, 6, (469), (1991).
- Koichi Okamoto and Masayuki Sekiguchi, Synaptic receptors and intracellular signal transduction in the cerebellum, Neuroscience Research, 9, 4, (213), (1991).
- Elias Aizenman, Lian-Hong Tang and Ian J. Reynolds, Effects of nicotinic agonists on the NMDA receptor, Brain Research, 551, 1-2, (355), (1991).
- Y. ARACAVA, M. M. FRÓES‐FERRÃO, E. F. R. PEREIRA and E. X. ALBUQUERQUE, Sensitivity of N‐Methyl‐D‐Aspartate (NMDA) and Nicotinic Acetylcholine Receptors to Ethanol and Pyrazole, Annals of the New York Academy of Sciences, 625, 1, (451-472), (2006).
- Jean L. Junien, François J. Roman, Gilles Brunelle and Xavier Pascaud, JO1784, a novel σ ligand, potentiates [3H]acetylcholine release from rat hippocampal slices, European Journal of Pharmacology, 200, 2-3, (343), (1991).
- S. Sagratella, A. Scotti de Carolis, A. Pèzzola and P. Popoli, Behavioural and electroencephalographic interactions between haloperidol and PCP/sigma ligands in the rat, Psychopharmacology, 105, 4, (485), (1991).
- Robert S. Fisher, 2. Introduction to the excitatory amino acid system, Epilepsy Research, 10, 1, (3), (1991).
- François J. Roman, Xavier Pascaud, Orla Duffy and Jean L. Junien, receptor complex modulation by neuropeptide Y and peptide YY in rat hippocampus in vitro, Neuroscience Letters, 122, 2, (202), (1991).
- Terriann Crisp, Jeannette M. Perrotti, Deborah L. Smith, Janet L. Stafinsky and David J. Smith, The local monoaminergic dependency of spinal ketamine, European Journal of Pharmacology, 194, 2-3, (167), (1991).
- C. Ferrarese, A. Guidotti, E. Costa, R.S. Miletich, K.C. Rice, B.R. de Costa, M.J. Fulham and G. Di Chiro, In vivo study of nmda-sensitive glutamate receptor by fluorothienylcycloexylpiperidine, a possible ligand for positron emission tomography, Neuropharmacology, 30, 8, (899), (1991).
- Arthur K. Cho, Masayuki Hiramatsu, Debra A. Schmitz, Toshitaka Nabeshima and Tsutomu Kameyama, Pharmacokinetic and pharmacodynamic properties of some phencyclidine analogs in rats, Pharmacology Biochemistry and Behavior, 39, 4, (947), (1991).
- Yukihiro Ohya, Nobuhiko Ochi, Naoki Mizutani, Chiemi Hayakawa and Kazuyoshi Watanabe, Nonketotic hyperglycinemia: Treatment with NMDA antagonist and consideration of neuropathogenesis, Pediatric Neurology, 7, 1, (65), (1991).
- John Church and Sophie Zeman, Ketamine promotes hippocampal CA1 pyramidal neuron loss after a short-duration ischemic insult in rats, Neuroscience Letters, 123, 1, (65), (1991).
- E. X. Albuquerque, A. C. S. Costa, M. Alkondon, K. P. Shaw, A. S. Ramoa and Y. Aracava, Functional Properties of the Nicotinic and Glutamatergic Receptors, Journal of Receptor Research, 11, 1-4, (603), (1991).
- S.S. Smith, Progesterone administration attenuates excitatory amino acid responses of cerebellar Purkinje cells, Neuroscience, 42, 2, (309), (1991).
- J. Velíšková, L. Velíšek, P. Mareš and R. Rokyta, Ketamine suppresses both bicuculline- and picrotoxin-induced generalized tonic-clonic seizures during ontogenesis, Pharmacology Biochemistry and Behavior, 37, 4, (667), (1990).
- Howard Mount, Rémi Quirion, Judity Kohn‐Alexander and Patricia Boksa, Subtypes of excitatory amino acid receptors involved in the stimulation of [3H]dopamine release from cell cultures of rat ventral mesencephalon, Synapse, 5, 4, (271-280), (2004).
- Ian H. Reynolds and Elizabeth A. Rush, Role of lipid solubility in the interaction of drugs with the N‐methyl‐D‐aspartate receptor, Synapse, 5, 1, (71-76), (2004).
- J.W. Mcdonald, F.S. Silverstein, D. Cardona, C. Hudson, R. Chen and M.V. Johnston, Systemic administration of mk-801 protects against N-methyl-d-aspartate-and quisqualate-mediated neurotoxicity in perinatal rats, Neuroscience, 36, 3, (589), (1990).
- Helmut Wachtel and Lechoslaw Turski, Glutamate: a new target in schizophrenia?, Trends in Pharmacological Sciences, 11, 6, (219), (1990).
- Elsebet Ø. Nielsen, Jørgen Drejer, Jang‐Ho J. Cha, Anne B. Young and Tage Honoré, Autoradiographic Characterization and Localization of Quisqualate Binding Sites in Rat Brain Using the Antagonist [3H]6‐Cyano‐7‐Nitroquinoxaline‐2,3‐Dione: Comparison with (R,S)‐[3H]α‐Amino‐3‐Hydroxy‐5‐Methyl‐4‐Isoxazolepropionic Acid Binding Sites, Journal of Neurochemistry, 54, 2, (686-695), (2006).
- L. Singh, E.H.F. Wong, A.C. Kesingland and M.D. Tricklebank, Evidence against an involvement of the haloperidol‐sensitive σ recognition site in the discriminative stimulus properties of (+)‐N‐allylnormetazocine ((+)‐SKF 10,047), British Journal of Pharmacology, 99, 1, (145-151), (2012).
- Varda Nadler, Yoel Kloog and Mordechai Sokolovsky, Distinctive structural requirement for the binding of uncompetitive blockers (phencyclidine-like drugs) to the NMDA receptor, European Journal of Pharmacology: Molecular Pharmacology, 188, 2-3, (97), (1990).
- Maria Dorota Majewska, James A. Bell and Edythe D. London, Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate, Brain Research, 537, 1-2, (328), (1990).
- John Church and David Lodge, Anticonvulsant actions of phencyclidine receptor ligands: Correlation with N-Methylaspartate Antagonism in vivo, General Pharmacology: The Vascular System, 21, 2, (165), (1990).
- David A. Hosford, Douglas W. Bonhaus and James O. McNamara, A radiohistochemical measure of [3H]TCP binding to the activated NMDA-receptor-gated ion channel in rat brain, Brain Research, 516, 2, (192), (1990).
- Tsukasa Sakurada, Yoichi Manome, Koichi Tan‐No, Shinobu Sakurada and Kensuke Kisara, The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N‐methyl‐d‐aspartate in mice, British Journal of Pharmacology, 101, 2, (307-310), (2012).
- George A. Palcos, Zan Wei Yang and James C. Byrd, Ontogeny of PCP and Sigma receptors in rat brain, Developmental Brain Research, 51, 2, (147), (1990).
- Patrizia Popoli, Marta Benedetti and Arsenia Scotti de Carolis, Influence of nimodipine and diltiazem, alone and in combination, on phencyclidine-induced effects in rats: an EEG and behavioural study, European Journal of Pharmacology, 191, 2, (141), (1990).
- Paal Klepstad, Atle Maurset, Enrica Ratti Moberg and Ivar Øye, Evidence of a role for NMDA receptors in pain perception, European Journal of Pharmacology, 187, 3, (513), (1990).
- Patricia C. Contreras, D-serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia, Neuropharmacology, 29, 3, (291), (1990).
- Frank R. DePietro and James C. Byrd, Effects of membrane fluidity on [3H]TCP binding to PCP receptors, Journal of Molecular Neuroscience, 2, 1, (45), (1990).
- Richard A. Morrisett, Carolyn C. Chow, Takuya Sakaguchi, Cheolsu Shin and James O. McNamara, Inhibition of Muscarinic‐Coupled Phosphoinositide Hydrolysis by N‐Methyl‐d‐Aspartate Is Dependent on Depolarization via Channel Activation, Journal of Neurochemistry, 54, 5, (1517-1525), (2006).
- T.S. Rao, H.S. Kim, J. Lehmann, L.L. Martin and P.L. Wood, Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (pcp) binding site: tentative evidence for pcp recognition sites not coupled to n-methyl-d-aspartate (nmda) receptors, Neuropharmacology, 10.1016/0028-3908(90)90005-C, 29, 3, (225-230), (1990).
- Ambrish J. Patel, Anthony Hunt and Coral Sanfeliu, Cell-type specific effects of N-methyl-d-aspartate on biochemical differentiation of subcortical neurons in culture, International Journal of Developmental Neuroscience, 8, 4, (379), (1990).
- Yukio Yoneda, Kiyokazu Ogita, Takeo Suzuki, Riyo Enomoto and Zuo Ping Ping, Competitive inhibition of NMDA-mediated responses by guanine nucleotides in brain synaptic membranes treated with Triton X-100, Neuroscience Research, 9, 2, (114), (1990).
- D.G. Herrera and H.A. Robertson, N--methyl-d-aspartate receptors mediate activation of the c-fos proto-oncogene in a model of brain injury, Neuroscience, 35, 2, (273), (1990).
- Hanan Frenk, Julius Miller, Jan N. Johannessen and David J. Mayer, Spinal paralysis and catalepsy induced by intrathecal injection of opioid agonists, Pharmacology Biochemistry and Behavior, 36, 2, (243), (1990).
- H. Jaffe, J.B. O'Neill, P.L. Hallberg, T. Kingan, G. Barbour, M. Lawson, L.D. Kwart, M.R. Ruff, C.B. Pert and K.R. Rao, Isolation and identification of a peptide from rat brain which inhibits [3H]TCP binding, International Journal of Biochemistry, 10.1016/0020-711X(90)90335-Z, 22, 3, (239-245), (1990).
- Karl L. R. Jansen, Ketamine–Can Chronic Use Impair Memory, International Journal of the Addictions, 25, 2, (133), (1990).
- Victor J. DeNoble, Keith W. Jones, Christina L. Schaeffer and Liana M. Bauerle, 3-((±)-2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid (CCP) and phencyclidine produce a deficit of passive avoidance retention in rats, European Journal of Pharmacology, 175, 2, (197), (1990).
- Evelyne Tremblay, Marie-Paule Roisin-Lallemand and Yehezkel Ben-Ari, Developmental study of [3H]TCP and [3H]glycine binding sites in the rat hippocampus, Developmental Brain Research, 57, 1, (21), (1990).
- Makoto Muramatsu, Chika Usuki-Ito and Hironaka Aihara, [3H]Minaprine binding to membrane preparation from rat brain, Neurochemistry International, 17, 1, (67), (1990).
- William L. Lanier, William J. Perkins, Bente R. Karlsson, James H. Milde, Bernd W. Scheithauer, Gary T. Shearman and John D. Michenfelder, The Effects of Dizocilpine Maleate (MK-801), an Antagonist of the N-Methyl-D-Aspartate Receptor, on Neurologic Recovery and Histopathology following Complete Cerebral Ischemia in Primates, Journal of Cerebral Blood Flow & Metabolism, 10, 2, (252), (1990).
- H. Koyuncuoǧlu, M. Güngör, H. Saǧduyu and F. Aricioǧlu, Suppression by ketamine and dextromethorphan of precipitated abstinence syndrome in rats, Pharmacology Biochemistry and Behavior, 35, 4, (829), (1990).
- James P. Apland and David J. Braitman, Effects of non-opioid antitussives on epileptiform activity and NMDA responses in hippocampal and olfactory cortex slices, Brain Research, 529, 1-2, (277), (1990).
- Laura C. Daniell, The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics, Pharmacology Biochemistry and Behavior, 36, 1, (111), (1990).
- J.W. McDonald, J.B. Penney, M.V. Johnston and A.B. Young, Characterization and regional distribution of strychnine-insensitive [3H]glycine binding sites in rat brain by quantitative receptor autoradiography, Neuroscience, 35, 3, (653), (1990).
- Richard Hall and John Murdoch, Brain protection: physiological and pharmacological considerations. Part II: the pharmacology of brain protection, Canadian Journal of Anaesthesia, 37, 7, (762), (1990).
- S. Schwarz, G.-Z. Zhou, A.G. Katki and D. Rodbard, l-Homocysteate stimulates [3H]MK-801 binding to the phencyclidine recognition site and is thus an agonist for the N-methyl-d-aspartate-operated cation channel, Neuroscience, 37, 1, (193), (1990).
- László Vécsei and M. Flint Beal, Intracerebroventricular injection of kynurenic acid, but not kynurenine, induces ataxia and stereotyped behavior in rats, Brain Research Bulletin, 25, 4, (623), (1990).
- Christopher S. Colwell, Martin R. Ralph and Michael Menaker, Do NMDA receptors mediate the effects of light on circadian behavior?, Brain Research, 523, 1, (117), (1990).
- Siegfried Schwarz, Guang-Zhao Zhou, Aspandiar G. Katki and David Rodbard, Differential Modulation by Cations of Sigma and Phencyclidine Binding Sites in Rat Brain, Journal of Receptor Research, 10, 1-2, (11), (1990).
- Haruhiko Shinozaki, Yasunori Gotoh and Ishida Michiko, Selective (NMDA) antagonists increase gastric motility in the rat, Neuroscience Letters, 113, 1, (56), (1990).
- Rachel Haring, R.Suzanne Zukin and Stephen R. Zukin, Photoaffinity labeling and binding studies reveal the existence of two types of phencyclidine receptors in the NCB-20 cell line, Neuroscience Letters, 112, 1, (92), (1990).
- Richard W. Ransom and Nancy L. Deschenes, Polyamines regulate glycine interaction with the N‐methyl‐D‐aspartate receptor, Synapse, 5, 4, (294-298), (2004).
- Jitendra Patel, William C. Zinkand, Andrea B. Klika, Thomas J. Mangano, Richard A. Keith and Andre I. Salama, 6,7‐Dinitroquinoxaline‐2,3‐Dione Blocks the Cytotoxicity of N‐Methyl‐D‐Aspartate and Kainate, but Not Quisqualate, in Cortical Cultures, Journal of Neurochemistry, 55, 1, (114-121), (2006).
- Graham D. Sher and Duncan Mitchell, N-methyl-d-aspartate receptors mediate responses of rat dorsal horn neurones to hindlimb ischemia, Brain Research, 522, 1, (55), (1990).
- S.A. Eaton and T.E. Salt, Thalamic NMDA receptors and nociceptive sensory synaptic transmission, Neuroscience Letters, 110, 3, (297), (1990).
- E. Godaux, G. Cheron and P. Mettens, Ketamine induces failure of the oculomotor neural integrator in the cat, Neuroscience Letters, 116, 1-2, (162), (1990).
- A.A. Reid, M.V. Mattson, B.R. de Costa, A. Thurkauf, A.E. Jacobson, J.A. Monn, K.C. Rice and R.B. Rothman, Specificity of phencyclidine-like drugs and benzomorphan opiates for two high affinity phencyclidine binding sites in guinea pig brain, Neuropharmacology, 29, 9, (811), (1990).
- Kiyokazu Ogita, Takeo Suzuki, Riyo Enomoto, Takao Ohgaki, Jun-ichi Katagawa, Shuji Uchida, Haruo Meguri and Yukio Yoneda, Profiles of binding in brain synaptic membranes treated with Triton X-100, Neuroscience Research, 9, 1, (35), (1990).
- Tadimeti S. Rao, Patricia C. Contreras and Paul L. Wood, Are N-methyl-d-aspartate (NMDA) and phencyclidine (PCP) receptors always functionally coupled to each other?, Neurochemistry International, 17, 1, (1), (1990).
- Yossef Itzhak and Ira Stein, Sigma binding states in the brain; An emerging concept for multiple sites and their relevance for psychiatric disorders, Life Sciences, 47, 13, (1073), (1990).
- Michael McMillian, Gary A. Pritchard and Lawrence G. Miller, Characterization of Ca2+-mobilizing excitatory amino acid receptors in cultured chick cortical cells, European Journal of Pharmacology: Molecular Pharmacology, 189, 4-5, (253), (1990).
- Geoffrey White, David M. Lovinger, Robert W. Peoples and Forrest F. Weight, Inhibition of N-methyl-l-aspartate activated ion current by desmethylimipramine, Brain Research, 537, 1-2, (337), (1990).
- Sherry Feig and Peter Lipton, N‐Methyl‐D‐Aspartate Receptor Activation and Ca2+ Account for Poor Pyramidal Cell Structure in Hippocampal Slices, Journal of Neurochemistry, 55, 2, (473-483), (2006).
- Ian J. Reynolds and Richard J. Miller, Allosteric Modulation of N-Methyl-D-Aspartate Receptors, , 10.1016/S1054-3589(08)60340-3, (101-126), (1990).
- FRANÇOIS J. ROMAN, XAVIER PASCAUD, BRIGITTE MARTIN, DANIEL VAUCHÉ and JEAN‐LOUIS JUNIEN, JO 1784, a potent and selective ligand for rat and mouse brain σ‐sites, Journal of Pharmacy and Pharmacology, 42, 6, (439-440), (2011).
- Merrit L. Quarum, Joel D. Parker, John F. W. Keana and Eckard Weber, (+)‐[3H]MK‐801 Binding Sites in Postmortem Human Brain, Journal of Neurochemistry, 54, 4, (1163-1168), (2006).
- David B. Clifford, John W. Olney, Ann M. Benz, Terry A. Fuller and Charles F. Zorumski, Ketamine, Phencyclidine, and MK‐801 Protect Against Kainic Acid‐Induced Seizure‐Related Brain Damage, Epilepsia, 31, 4, (382-390), (2007).
- John Church and David Lodge, Failure of σ‐receptor ligands to reduce the excitatory actions of N‐methyl‐DL‐aspartate on rat spinal neurons in‐vivo, Journal of Pharmacy and Pharmacology, 42, 1, (56-57), (2011).
- L.J. Herberg and I.C. Rose, Excitatory amino acid pathways in brain-stimulation reward, Behavioural Brain Research, 39, 3, (230), (1990).
- Hadas Lamdani-Itkin, Yoel Kloog and Mordechai Sokolovsky, Modulation of glutamate-induced uncompetitive blocker binding to the NMDA receptor by temperature and by glycine, Biochemistry, 29, 16, (3987), (1990).
- E.J. Fletcher, C. Drew, D. Lodge and C.T. O'Shaughnessy, Efflux of rubidium in rat cortical synaptosomes is blocked by sigma and dextromethorphan binding site ligands, Neuropharmacology, 28, 7, (661), (1989).
- Horia Allaoua and Robert Chicheportiche, Anaesthetic properties of phencyclidine (PCP) and analogues may be related to their interaction with Na+ channels, European Journal of Pharmacology, 163, 2-3, (327), (1989).
- Kevin T. Finnegan, John J. Skratt, Ian Irwin and James W. Langston, The receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats, Neuroscience Letters, 105, 3, (300), (1989).
- Po-Wu Gean, Patricia Shinnick-Gallagher and Anthony C. Anderson, Spontaneous epileptiform activity and alteration of GABA- and of NMDA-mediated neurotransmission in amygdala neurons kindled in vivo, Brain Research, 494, 1, (177), (1989).
- John W. Olney, Excitotoxicity and N‐methyl‐D‐Aspartate receptors, Drug Development Research, 17, 4, (299-319), (2004).
- Philip Wahl, Arne Schousboe, Tage Honoré and Jorgen Drejer, Glutamate‐Induced Increase in Intracellular Ca2+ in Cerebral Cortex Neurons Is Transient in Immature Cells but Permanent in Mature Cells, Journal of Neurochemistry, 53, 4, (1316-1319), (2006).
- J.F. Blake, R.G. Yates, M.W. Brown and G.L. Collingridge, 6‐Cyano‐7‐nitroquinoxaline‐2,3‐dione as an excitatory amino acid antagonist in area CA1 of rat hippocampus, British Journal of Pharmacology, 97, 1, (71-76), (2012).
- T. Priestley, G.N. Woodruff and J.A. Kemp, Antagonism of responses to excitatory amino acids on rat cortical neurones by the spider toxin, argiotoxin636, British Journal of Pharmacology, 97, 4, (1315-1323), (2012).
- E. J. Fletcher, J. D. Millar, S. Zeman and D. Lodge, Non‐Competitive Antagonism of N‐Methyl‐D‐Aspartate by Displacement of an Endogenous Glycine‐Like Substance, European Journal of Neuroscience, 1, 3, (196-203), (2006).
- T. Honoré, Excitatory amino acid receptor subtypes and specific antagonists, Medicinal Research Reviews, 9, 1, (1-23), (2006).
- Charles Kennedy and Graeme Henderson, An examination of the putative σ‐receptor in the mouse isolated vas deferens, British Journal of Pharmacology, 98, 2, (429-436), (2012).
- Mark L. Mayer, Ladislav Vyklicky and Evelyne Sernagor, A physiologist's view of the N‐methyl‐D‐Aspartate receptor: An allosteric ion channel with multiple regulatory sites, Drug Development Research, 17, 4, (263-280), (2004).
- Robert F. Halliwell, John A. Peters and Jeremy J. Lambert, The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK‐801: a voltage clamp study on neuronal cells in culture, British Journal of Pharmacology, 96, 2, (480-494), (2012).
- John W. Olney, Excitatory amino acids and neuropsychiatrie disorders, Biological Psychiatry, 26, 5, (505), (1989).
- Anne Jackson and D.J. Sanger, Conditioned taste aversions induced by phencyclidine and other antagonists of N-methyl-d-aspartate, Neuropharmacology, 28, 5, (459), (1989).
- Eduardo R. Butelman, A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task, Pharmacology Biochemistry and Behavior, 34, 1, (13), (1989).
- H. McLennan, Pharmacology of receptors for excitatory amino acids, Drug Development Research, 17, 4, (253-262), (2004).
- David L. Reich and George Silvay, Ketamine: an update on the first twenty-five years of clinical experience, Canadian Journal of Anaesthesia, 10.1007/BF03011442, 36, 2, (186-197), (1989).
- A.S. Foutz, J. Champagnat and M. Denavit-Saubié, Involvement of N-methyl-d-aspartate (NMDA) receptors in respiratory rhythmogenesis, Brain Research, 500, 1-2, (199), (1989).
- Barbara Ahlemeyer and Josef Krieglstein, Testing drug effects against hypoxic damage of cultured neurons during long-term recovery, Life Sciences, 45, 9, (835), (1989).
- Yossef Itzhak, Different modulation of the binding to two phencyclidine (PCP) receptor subtypes: Effects of agonists and antagonists, Neuroscience Letters, 104, 3, (314), (1989).
- S.K. O'neill and G.T. Bolger, Phencyclidine and MK-801: A behavioral and neurochemical comparison of their interactions with dihydropyridine calcium antagonists, Brain Research Bulletin, 22, 4, (611), (1989).
- Karl B. Thor, David P. Blais and William C. de Groat, Behavioral analysis of the postnatal development of micturition in kittens, Developmental Brain Research, 46, 1, (137), (1989).
- Carl L. Faingold, William E. Hoffmann and Donald M. Caspary, Effects of excitant amino acids on acoustic responses of inferior colliculus neurons, Hearing Research, 40, 1-2, (127), (1989).
- Duncan P. Taylor and Susan H. Behling, Phencyclidine acts as an N‐methyl‐D‐Aspartate agonist in vitro, Drug Development Research, 17, 1, (63-70), (2004).
- Scott H. Chandler, Evidence for excitatory amino acid transmission between mesencephalic nucleus of V afferents and jaw-closer motoneurons in the guinea pig, Brain Research, 477, 1-2, (252), (1989).
- Paul L. Wood and Tadimeti S. Rao, NMDA-coupled and uncoupled forms of the PCP receptor: Preliminary in vivo evidence for PCP receptor subtypes, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/0278-5846(89)90140-1, 13, 3-4, (519-523), (1989).
- M.P. Kavanaugh, B.A.C. Tester and E. Weber, Interaction of MK-801 with the nicotinic acetylcholine receptor-associated ion channel from electroplax, European Journal of Pharmacology, 164, 2, (397), (1989).
- Anne M. Morin, Haruo Hattori, Claude G. Wasterlain and Darrell Thomson, [3H]MK-801 binding sites in neonate rat brain, Brain Research, 487, 2, (376), (1989).
- M.A. Hashim and D. Bieger, Excitatory amino acid receptor-mediated activation of solitarial deglutitive loci, Neuropharmacology, 28, 9, (913), (1989).
- Linda M. Aanonsen and Virginia S. Seybold, Phencyclidine and sigma receptors in rat spinal cord: Binding characterization and quantitative autoradiography, Synapse, 4, 1, (1-10), (2004).
- F. Roman, X. Pascaud, G. Chomette, L. Bueno and J.L. Junien, Autoradiographic localization of sigma opioid receptors in the gastrointestinal tract of the guinea pig, Gastroenterology, 97, 1, (76), (1989).
- D.T. Manallack, D. Lodge and P.M. Beart, Subchronic administration of MK-801 in the rat decreases cortical binding of [3H]d-AP5, suggesting down-regulation of the corticalN-methyl-d-aspartate receptors, Neuroscience, 30, 1, (87), (1989).
- W. Hauber and W. J. Schmidt, Effects of intrastriatal blockade of glutamatergic transmission on the acquisition of T-maze and radial maze tasks, Journal of Neural Transmission, 78, 1, (29), (1989).
- Yukio Yoneda, Kiyokazu Ogita, Takao Ohgaki, Shuji Uchida and Haruo Meguri, N-Methyl-d-aspartate-sensitive [3H]glutamate binding sites in brain synaptic membranes treated with Triton X-100, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1012, 1, (74), (1989).
- Elizabeth Swearengen and C. Chavkin, Comparison of opioid and GABA receptor control of excitability and membrane conductance in hippocampal CA1 pyramidal cells in rat, Neuropharmacology, 28, 7, (689), (1989).
- Donald W. Miller, D.L. Yourick and R.E. Tessel, Antagonism of methoxyflurane-induced anesthesia in rats by benzodiazepine inverse agonists, European Journal of Pharmacology, 173, 1, (1), (1989).
- Yukio Yoneda and Kiyokazu Ogita, Labeling of NMDA receptor channels by [3H]MK-801 in brain synaptic membranes treated with Triton X-100, Brain Research, 499, 2, (305), (1989).
- William J. Perkins, William L. Lanier, Bente R. Karlsson, James H. Milde and John D. Michenfelder, The effect of the excitatory amino acid receptor antagonist dizocilipine maleate (MK-801) on hemispheric cerebral blood flow and metabolism in dogs: modification by prior complete cerebral ischemia, Brain Research, 498, 1, (34), (1989).
- Arthur S. Foutz and Monique Denavit-Saubié, Differentiation of phencyclidine and sigma receptor types affecting the central inspiratory termination mechanism in cat, Life Sciences, 45, 14, (1285), (1989).
- Yukihiro Yoshida, Toru Nishikawa, Yasuyuki Tanii and Kiyohisa Takahashi, Frontal decortication decreases the affinity ofN-(1-[2-thienyl]cyclohexyl)[3H]piperidine binding to rat striatum Frontal decortication; Striatum, Brain Research, 499, 1, (179), (1989).
- Masayuki Hiramatsu, Arthur K. Cho and Nabeshima Toshitaka, Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine, European Journal of Pharmacology, 166, 3, (359), (1989).
- Stefano Sagratella and Arsenia Scotti De Carolis, Pentobarbital-like electroencephalographic rubral rhythm induced by ketamine in rabbits, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 13, 1-2, (259), (1989).
- Atle Maurset, Lasse A. Skoglund, Olav Hustveit and Ivar Øye, Comparison of ketamine and pethidine in experimental and postoperative pain, Pain, 36, 1, (37), (1989).
- J.H. Schneiderman and J.F. MacDonald, Excitatory amino acid blockers differentially affect bursting of In vitro hippocampal neurons in two pharmacological models of epilepsy, Neuroscience, 31, 3, (593), (1989).
- H.S. Swartzwelder, C. Ferrari, W.W. Anderson and W.A. Wilson, The drug MK-801 attenuates the development, but not the expression, of long-term potentiation and stimulus train-induced bursting in hippocampal slices, Neuropharmacology, 28, 5, (441), (1989).
- T. Honoré, J. Drejer, E.Ø. Nielsen, J.C. Watkins, H.J. Olverman and M. Nielsen, Molecular target size analyses of the NMDA-receptor complex in rat cortex, European Journal of Pharmacology: Molecular Pharmacology, 172, 3, (239), (1989).
- Bruce E. Hetzler and Anne-Marie Melk, Effects of ketamine, naloxone, and physostigmine on flash evoked potentials in rat superior colliculus, Pharmacology Biochemistry and Behavior, 32, 2, (511), (1989).
- Loris D. McVittie and David R. Sibley, Solubilization of phencyclidine receptors from rat cerebral cortex in an active ligand binding state, Life Sciences, 44, 23, (1793), (1989).
- Mark D. Tricklebank, Lakhbir Singh, Ryszard J. Oles, Cliff Preston and Susan D. Iversen, The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor, European Journal of Pharmacology, 167, 1, (127), (1989).
- Donald M. Caspary and Carl L. Faingold, Non-N-methyl-d-aspartate receptors may mediate ipsilateral excitation at lateral superior olivary synapses, Brain Research, 503, 1, (83), (1989).
- P. Loikas and I. Hilakivi, Effects of Kynurenic Acid and Ketamine on Neonatal Sleep in Rats, Pharmacology & Toxicology, 64, 2, (185-189), (2009).
- L. Velíšek, R. Mikolášová, S. Blanková-Vaňková and P. Mareš, Effects of ketamine on metrazol-induced seizures during ontogenesis in rats, Pharmacology Biochemistry and Behavior, 32, 2, (405), (1989).
- Caroline E. Herron and Ian D. Forsythe, Hippocampal synaptic transmission: Regulation of the NMDA receptor-mediated component, Comparative Biochemistry and Physiology Part A: Physiology, 93, 1, (203), (1989).
- Isabelle Chaudieu, Jacques Vignon, Michèle Chicheportiche, Jean-Marc Kamenka, Gérard Trouiller and Robert Chicheportiche, Role of the aromatic group in the inhibition of phencyclidine binding and dopamine uptake by PCP analogs, Pharmacology Biochemistry and Behavior, 32, 3, (699), (1989).
- J.T. Wroblewski, E. Fadda, J. Mazzetta, J.W. Lazarewicz and E. Costa, Glycine and d-serine act as positive modulators of signal transduction at N-methyl-d-aspartate sensitive glutamate receptors in cultured cerebellar granule cells, Neuropharmacology, 28, 5, (447), (1989).
- M. P. Kavanaugh, J. Parker, D. H. Bobker, J. F. W. Keana and E. Weber, Solubilization and Characterization of σ‐Receptors from Guinea Pig Brain Membranes, Journal of Neurochemistry, 53, 5, (1575-1580), (2006).
- Ian J. Reynolds and Richard J. Miller, [3H]MK801 binding to the NMDA receptor/ionophore complex is regulated by divalent cations: evidence for multiple regulatory sites, European Journal of Pharmacology, 151, 1, (103), (1988).
- Michael Williams, Patricia A. Loo, Deborah E. Murphy, Albert F. Braunwalder, Michael F. Jarvis and Matthew A. Sills, The N-Methyl-D-Aspartate Receptor Complex, Journal of Receptor Research, 8, 1-4, (195), (1988).
- Erik H. F. Wong, Antony R. Knight and Geoffrey N. Woodruff, [3H]MK‐801 Labels a Site on the N‐Methyl‐D‐Aspartate Receptor Channel Complex in Rat Brain Membranes, Journal of Neurochemistry, 50, 1, (274-281), (2006).
- Robert J Brady and John W Swann, Suppression of ictal-like activity by kynurenic acid does not correlate with its efficacy as an NMDA receptor antagonist, Epilepsy Research, 2, 4, (232), (1988).
- Peter Andiné, Ingemar Jacobson and Henrik Hagberg, Calcium Uptake Evoked by Electrical Stimulation is Enhanced Postischemically and Precedes Delayed Neuronal Death in CA1 of Rat Hippocampus: Involvement of N-Methyl-D-Aspartate Receptors, Journal of Cerebral Blood Flow & Metabolism, 8, 6, (799), (1988).
- Margaret Lalies, Derek N. Middlemiss and Richard Ransom, Stereoselective antagonism of NMDA-stimulated noradrenaline release from rat hippocampal slices by MK-801, Neuroscience Letters, 91, 3, (339), (1988).
- C.G. Parsons, H. Gibbens, T.S.I. Magnago and P.M. Headley, At which ‘sigma’ site are the spinal actions of ketamine mediated?, Neuroscience Letters, 85, 3, (322), (1988).
- Ian J. Reynolds and Richard J. Miller, Tricyclic antidepressants block N‐methyl‐D‐aspartate receptors: similarities to the action of zinc, British Journal of Pharmacology, 95, 1, (95-102), (2012).
- , Neurotox '88—An international symposium on neuropharmacology and pesticide action, Pesticide Science, 24, 1, (63-95), (2006).
- A.S. Ramoa and E.X. Albuquerque, Phencyclidine and some of its analogues have distinct effects on NMDA receptors of rat hippocampal neurons, FEBS Letters, 235, 1-2, (156-162), (2001).
- Yoel Kloog, Varda Nadler and Mordechai Sokolovsky, Mode of binding of [3H]dibenzocycloalkenimine (MK‐801) to the N‐methyl‐D‐aspartate (NMDA) receptor and its therapeutic implication, FEBS Letters, 230, 1-2, (167-170), (2001).
- Maria Erecińska, David Nelson and Ian A. Silver, Interactions of benztropine, atropine and ketamine with veratridine‐activated sodium channels: effects on membrane depolarization, K+‐efflux and neutrotransmitter amino acid release, British Journal of Pharmacology, 94, 3, (871-881), (2012).
- D. Lodge, S.N. Davies, M.G. Jones, J. Millar, D.T. Manallack, P.L. Ornstein, A.J.M. Verberne, N. Young and P.M. Beart, A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonists, British Journal of Pharmacology, 95, 3, (957-965), (2012).
- Roger Marrannes, Roland Willems, Erik De Prins and Albert Wauquier, Evidence for a role of the N-methyl-d-aspartate (NMDA) receptor in cortical spreading depression in the rat, Brain Research, 457, 2, (226), (1988).
- E. Oshima and C.D. Richards, An in vitro investigation of the action of ketamine on excitatory synaptic transmission in the hippocampus of the guinea-pig, European Journal of Pharmacology, 148, 1, (25), (1988).
- Richard B. Rothman, Victor Bykov, Amy-Hauck Newman, A.E. Jacobson and Kenner C. Rice, Interaction of enantiomeric pairs of opiates with phencyclidine binding sites in rat brain: Identification of (+) pentazocine as a ligand potentially suitable for imaging sigma binding sites using positron emission tomography, Neuropeptides, 12, 1, (1), (1988).
- Mark S. Sonders, John F.W. Keana and Eckard Weber, Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action, Trends in Neurosciences, 11, 1, (37), (1988).
- Lawrence D. Snell, Robert S. Morter and Kenneth M. Johnson, Structural requirements for activation of the glycine receptor that modulates the N-methyl-D-aspartate operated ion channel, European Journal of Pharmacology, 156, 1, (105), (1988).
- Munhyang Lee, Howard K. Strahlendorf and Jean C. Strahlendorf, Differential effects of N-methyl-d-aspartic acid and l-homocysteic acid on cerebellar Purkinje neurons, Brain Research, 456, 1, (104), (1988).
- Linda M. Pullan, Receptor specific inhibition of N-methyl-d-aspartate stimulated 22Na flux from rat hippocampal slices by phencyclidine and other drugs, Neuropharmacology, 27, 5, (493), (1988).
- Ifat Ambar, Yoel Kloog and Mordechai Sokolovsky, Solubilization of Rat Brain Phencyclidine Receptors in an Active Binding Form That Is Sensitive to N‐Methyl‐d‐Aspartate Receptor Ligands, Journal of Neurochemistry, 51, 1, (133-140), (2006).
- Su-Jin Yi, Lawrence D. Snell and Kenneth M. Johnson, Linkage between phencyclidine (PCP) and N-methyl-d-aspartate (NMDA) receptors in the cerebellum, Brain Research, 445, 1, (147), (1988).
- Bowen Y. Wong, Douglas A. Coulter, Dennis W. Choi and David A. Prince, Dextrorphan and dextromethorphan, common antitussives, are antiepileptic and antagonize in brain slices, Neuroscience Letters, 85, 2, (261), (1988).
- Stuart E. Dryer, Excitatory amino acid-evoked membrane currents and excitatory synaptic transmission in lamprey reticulospinal neurons, Brain Research, 443, 1-2, (173), (1988).
- Dirk Sauer, Jörg Nuglisch, Christine Rossberg, Hans-Dieter Mennel, Thomas Beck, Gerhard Wilhelm Bielenberg and Josef Krieglstein, Phencyclidine reduces postischemic neuronal necrosis in rat hippocampus without changing blood flow, Neuroscience Letters, 91, 3, (327), (1988).
- Richard W. Ransom and Nancy L. Stec, Inhibition of N-methyl-d-aspartate evoked sodium flux by MK-801, Brain Research, 444, 1, (25), (1988).
- Anne Jackson and D. J. Sanger, Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-d-aspartate receptors?, Psychopharmacology, 96, 1, (87), (1988).
- Leif Wiklund, Gila Behzadi, Peter Kalén, P.Max Headley, Lina S. Nicolopoulos, Chris G. Parsons and David C. West, Autoradiographic and electrophysiological evidence for excitatory amino acid transmission in the periaqueductal gray projection to nucleus raphe magnus in the rat, Neuroscience Letters, 93, 2-3, (158), (1988).
- M.E. Gilbert, The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures, Brain Research, 463, 1, (90), (1988).
- Thomas Klockgether, Lechoslaw Turski, Michael Schwarz, Karl-Heinz Sontag and John Lehmann, Paradoxical convulsant action of a novel non-competitiveN-methyl-d-aspartate (NMDA) antagonist, tiletamine, Brain Research, 461, 2, (343), (1988).
- J. Drejer and T. Honoré, New quinoxalinediones show potent antagonism of quisqualate responses in cultured mouse cortical neurons, Neuroscience Letters, 87, 1-2, (104), (1988).
- Stephen N. Davies, David Martin, John D. Millar, Julia A. Aram, John Church and David Lodge, Differences in results from in vivo and in vitro studies on the use-dependency of N-methylaspartate antagonism by MK-801 and other phencyclidine receptor ligands, European Journal of Pharmacology, 145, 2, (141), (1988).
- M.A. Rogawski, M. Pieniek, S. Suzuki and J.M.H. ffrench-Mullen, Phencyclidine selectively blocks the sustained voltage-dependent potassium conductance in PC12 cells, Brain Research, 456, 1, (38), (1988).
- J.David Leander, Ronald R. Lawson, Paul L. Ornstein and Dennis M. Zimmerman, N-Methyl-d-aspartic acid-induced lethality in mice: selective antagonism by phencylidine-like drugs, Brain Research, 448, 1, (115), (1988).
- Cynthia J. Davenport, Hannelore Monyer and Dennis W. Choi, Tetrahydroaminoacridine selectively attenuates NMDA receptor-mediated neurotoxicity, European Journal of Pharmacology, 154, 1, (73), (1988).
- A.T. Malouf, E. Swearengen and C. Chavkin, Comparison of the actions of phencyclidine and sigma ligands on CA1 hippocampal pyramidal neurons in the rat, Neuropharmacology, 27, 11, (1161), (1988).
- S.N. Davies, S.T. Alford, E.J. Coan, R.A.J. Lester and G.L. Collingridge, Ketamine blocks an NMDA receptor-mediated component of synaptic transmission in rat hippocampus in a voltage-dependent manner, Neuroscience Letters, 92, 2, (213), (1988).
- O.A. Krishtal, S.V. Smirnov and Yu.V. Osipchuk, Changes in the state of the excitatory synaptic system in the hippocampus on prolonged exposure to excitatory amino acids and antagonists, Neuroscience Letters, 85, 1, (82), (1988).
- Yossef Itzhak and Mabda Khouri, Regulation of the binding of σ- and phencyclidine (PCP)-receptor ligands in rat brain membranes by guanine nucleotides and ions, Neuroscience Letters, 85, 1, (147), (1988).
- Greg C. Rigdon and Robert S. Dyers, Ketamine alters rat flash evoked potentials, Pharmacology Biochemistry and Behavior, 30, 2, (421), (1988).
- Frank W. Marcoux, James E. Goodrich and Mark A. Dominick, Ketamine prevents ischemic neuronal injury, Brain Research, 452, 1-2, (329), (1988).
- Mariella Bertolino, Stefano Vicini, JoAnn Mazzetta and Erminio Costa, Phencyclidine and glycine modulate NMDA-activated high conductance cationic channels by acting at different sites, Neuroscience Letters, 84, 3, (351), (1988).
- Yoshimi Ikemoto and Norio Akaike, The glutamate-induced chloride current in Aplysia neurones lacks pharmacological properties seen for excitatory responses to glutamate, European Journal of Pharmacology, 150, 3, (313), (1988).
- T.E. Salt, D.G. Wilson and S.K. Prasad, Antagonism of N‐methylaspartate and synaptic responses of neurones in the rat ventrobasal thalamus by ketamine and MK‐801, British Journal of Pharmacology, 94, 2, (443-448), (2012).
- John F.W. Keana, Michael W. Scherz, Merrit Quarum, Mark S. Sonders and Eckard Weber, Synthesis and characterization of a radiolabelled derivative of the phencyclidine/N-methyl-D-aspartate receptor ligand (+)MK-801 with high specific radioactivity, Life Sciences, 43, 12, (965), (1988).
- Debra A. Bennett, Patrick S. Bernard and Caryl L. Amrick, A comparison of PCP-like compounds for NMDA antagonism in two models, Life Sciences, 42, 4, (447), (1988).
- J.A. Harvey, I. Gormezano, V.A. Cool-Hauser and C.W. Schindler, Effects of LSD on classical conditioning as a function of CS-UCS interval: Relationship to reflex facilitation, Pharmacology Biochemistry and Behavior, 30, 2, (433), (1988).
- Yoel Kloog, Rachel Haring and Mordechai Sokolovsky, Kinetic characterization of the phencyclidine-N-methyl-D-aspartate receptor interaction: evidence for a steric blockade of the channel, Biochemistry, 27, 3, (843), (1988).
- Dennis W. Choi and Vara Viseskul, Opioids and non-opioid enantiomers selectively attenuate N-methyl-D-aspartate neurotoxicity on cortical neurons, European Journal of Pharmacology, 155, 1-2, (27), (1988).
- Hilarey R. Feeser, Jay L. Kadis and David A. Prince, Dextromethorphan, a common antitussive, reduces kindled amygdala seizures in the rat, Neuroscience Letters, 86, 3, (340), (1988).
- Mark J. Benvenga and Theodore C. Spaulding, Amnesic effect of the novel anticonvulsant MK-801, Pharmacology Biochemistry and Behavior, 30, 1, (205), (1988).
- R.L. HAYES, L.W. JENKINS, B.G. LYETH, R.L. BALSTER, S.E. ROBINSON, G.L. CLIFTON, J.F. STUBBINS and H.F. YOUNG, Pretreatment with Phencyclidine, anN-Methyl-d-Aspartate Antagonist, Attenuates Long-Term Behavioral Deficits in the Rat Produced by Traumatic Brain Injury, Journal of Neurotrauma, 5, 4, (259), (1988).
- Nobuo Nagano, Hideki Ono and Hideomi Fukuda, Inhibitory effect of phencyclidine on rat spinal reflexes, General Pharmacology: The Vascular System, 19, 6, (795), (1988).
- M.F. Piercey and C.A. Ray, Dramatic limbic and cortical effects mediated by high affinity PCP receptors, Life Sciences, 43, 4, (379), (1988).
- Gerald W. Bourne, Barbara Esplin and Radan Čapek, Disinhibitory effect of phencyclidine in the hippocampus in vitro: PCP receptors implicated, European Journal of Pharmacology, 150, 1-2, (67), (1988).
- H.J. Olverman, A.W. Jones and J.C. Watkins, [3H]D-2-amino-5-phosphonopentanoate as a ligand for N-methyl-d-aspartate receptors in the mammalian central nervous system, Neuroscience, 26, 1, (1), (1988).
- N.G. Bowery, E.H.F. Wong and A.L. Hudson, Quantitative autoradiography of [3H]‐MK‐801 binding sites in mammalian brain, British Journal of Pharmacology, 93, 4, (944-954), (2012).
- Theodore J. Cicero, Edward R. Meyer and Roy D. Bell, Characterization and possible opioid modulation of N-methyl-D-aspartic acid induced increases in serum luteinizing hormone levels in the developing male rat, Life Sciences, 42, 18, (1725), (1988).
- Mark L. Mayer and Gary L. Westbrook, The physiology of excitatory amino acids in the vertebrate central nervous system, Progress in Neurobiology, 28, 3, (197), (1987).
- Dennis W. Choi, Dextrorphan and dextromethorphan attenuate glutamate neurotoxicity, Brain Research, 403, 2, (333), (1987).
- Mark L. Mayer and Gary L. Westbrook, Cellular mechanisms underlying excitotoxicity, Trends in Neurosciences, 10, 2, (59), (1987).
- Stephen Peters and Dennis W. Choi, Quinolinate is a weak excitant of cortical neurons in cell culture, Brain Research, 420, 1, (1), (1987).
- Susan M. Jones, L.D. Snell and K.M. Johnson, Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens, Neuropharmacology, 26, 2-3, (173), (1987).
- Patricia A. Loo, Albert F. Braunwalder, Michael Williams and Matthew A. Sills, The novel anticonvulsant MK-801 interacts with central phencyclidine recognition sites in rat brain, European Journal of Pharmacology, 135, 2, (261), (1987).
- Lawrence D. Snell, Susan M. Jones and Kenneth M. Johnson, Inhibition of hippocampal [3H]norepinephrine release by phencyclidine is dependent on potassium concentration, Neuroscience Letters, 78, 3, (333), (1987).
- Mark D. Tricklebank, Lakhbir Singh, Ryszard J. Oles, Erik H.F. Wong and Susan D. Iversen, A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine, European Journal of Pharmacology, 141, 3, (497), (1987).
- John W. Olney, Madelon T. Price, K.Shahid Salles, J. Labruyere, R. Ryerson, K. Mahan, G. Frierdich and L. Samson, L-Homocysteic acid: An endogenous excitotoxic ligand of the NMDA receptor, Brain Research Bulletin, 19, 5, (597), (1987).
- Robert P. Compton, Patricia C. Contreras, Thomas L. O'Donohue and Joseph B. Monahan, The N-methyl-D-aspartate antagonist, 2-amino-7-phosphonoheptanoate, produces phencyclidine-like behavioral effects in rats, European Journal of Pharmacology, 136, 1, (133), (1987).
- Patricia C. Contreras, Joseph B. Monahan, Thomas H. Lanthorn, Linda M. Pullan, Debora A. DiMaggio, Gail E. Handelmann, Nancy M. Gray and Thomas L. O’Donohue, Phencyclidine, Molecular Neurobiology, 1, 3, (191), (1987).
- E.J. Coan and G.L. Collingridge, Characterization of an N-methyl-d-aspartate receptor component of synaptic transmission in rat hippocampal slices, Neuroscience, 22, 1, (1), (1987).
- John Lehmann, Josef A. Schneider and Michael Williams, Chapter 4 Excitatory Amino Acids and Mammalian CNS Function, , 10.1016/S0065-7743(08)61152-5, (31-40), (1987).
- John W. Olney, Madelon T. Price, Joann Labruyere, K. Shahid Salles, Gregory Frierdich, Mary Mueller and Emily Silverman, Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists, European Journal of Pharmacology, 142, 2, (319), (1987).
- C.H. Vanderwolf, Suppression of serotonin-dependent cerebral activation: a possible mechanism of action of some psychotomimetic drugs, Brain Research, 414, 1, (109), (1987).
- Stephen N. Davies, John Church and David Lodge, Non-pharmacological effects of the use of microelectrophoresis and pressure ejection of drugs in combination, Journal of Neuroscience Methods, 20, 3, (221), (1987).
- Rachel Haring, Yoel Kloog, Asher Kalir and Mordehai Sokolovsky, Binding studies and photoaffinity labeling identify two classes of phenycyclidine receptors in rat brain, Biochemistry, 26, 18, (5854), (1987).
- Daniel C. Javitt, Alan Jotkowitz, Ratna Sircar and Stephen R. Zukin, Non-competitive regulation of phencyclidine/σ-receptors by the receptor antagonist d-(−)-2-amino-5-phosphonovaleric acid, Neuroscience Letters, 78, 2, (193), (1987).
- Graham E. Fagg, Phencyclidine and related drugs bind to the activated receptor-channel complex in rat brain membranes, Neuroscience Letters, 76, 2, (221), (1987).
- Ratna Sircar, Michael Rappaport, Roxanne Nichtenhauser and Stephan R. Zukin, The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/gd-receptor, Brain Research, 435, 1-2, (235), (1987).
- Amy B. MacDermott and Nicholas Dale, Receptors, ion channels and synaptic potentials underlying the integrative actions of excitatory amino acids, Trends in Neurosciences, 10, 7, (280), (1987).
- Malte E. Kornhuber, Christian Walther and Johannes Kornhuber, Phencyclidine depresses transmitter release at the neuromuscular synapse of the locust, Neuroscience Letters, 83, 1-2, (185), (1987).
- Pierre Etienne and Michel Baudry, Calcium dependent aspects of synaptic plasticity, excitatory amino acid neurotransmission, brain aging and schizophrenia: A unifying hypothesis, Neurobiology of Aging, 8, 4, (362), (1987).
- J. Drejer and T. Honoré, Phencyclidine analogues inhibit NMDA-stimulated [3H]GABA release from cultured cortex neurons, European Journal of Pharmacology, 143, 2, (287), (1987).
- G.J. Lees, Effects of ketamine on the in vivo toxicity of quinolinate and in the rat hippocampus, Neuroscience Letters, 78, 2, (180), (1987).
- S.M. Rothman, J.H. Thurston, R.E. Hauhart, G.D. Clark and J.S. Solomon, Ketamine protects hippocampal neurons from anoxia in vitro, Neuroscience, 21, 3, (673), (1987).
- Lawrence D. Snell, Robert S. Morter and Kenneth M. Johnson, Glycine potentiates [3H]TCP binding to rat cortical membranes, Neuroscience Letters, 83, 3, (313), (1987).
- N.R. Burton, D.A.S. Smith and T.W. Stone, The mouse neocortical slice: Preparation and responses to excitatory amino acids, Comparative Biochemistry and Physiology Part C: Comparative Pharmacology, 88, 1, (47), (1987).
- E.J. Coan and G.L. Collingridge, Effects of phencyclidine, SKF 10,047 and related psychotomimetic agents on N‐methyl‐d‐aspartate receptor mediated synaptic responses in rat hippocampal slices, British Journal of Pharmacology, 91, 3, (547-556), (2012).
- S. Sagratella, C. Frank and Arsenia Scotti de Carolis, Effects of ketamine and (+)cyclazocine on 4-aminopyridine and “magnesium free” epileptogenic activity in hippocampal slices of rats, Neuropharmacology, 26, 8, (1181), (1987).
- Jose Hernándéz-Cáceres, Raul Macias-González, Gustav Brožek and Jan Bureš, Systemic ketamine blocks cortical spreading depression but does not delay the onset of terminal anoxic depolarization in rats, Brain Research, 437, 2, (360), (1987).
- J.C. Watkins and H.J. Olverman, Agonists and antagonists for excitatory amino acid receptors, Trends in Neurosciences, 10, 7, (265), (1987).
- Carl W. Cotman, Daniel T. Monaghan, Ole P. Ottersen and Jon Storm-Mathisen, Anatomical organization of excitatory amino acid receptors and their pathways, Trends in Neurosciences, 10, 7, (273), (1987).
- R.H. Evans, S.J. Evans, P.C. Pook and D.C. Sunter, A comparison of excitatory amino acid antagonists acting at primary afferent C fibres and motoneurones of the isolated spinal cord of the rat, British Journal of Pharmacology, 91, 3, (531-537), (2012).
- Milena Cavazzuti, Carlo A. Porro, Gian Paolo Biral, Carlo Benassi and Gian Carlo Barbieri, Ketamine Effects on Local Cerebral Blood Flow and Metabolism in the Rat, Journal of Cerebral Blood Flow & Metabolism, 7, 6, (806), (1987).
- Janice P. Kim, Jae-young Koh and Dennis W. Choi, l-Homocysteate is a potent neurotoxin on cultured cortical neurons, Brain Research, 437, 1, (103), (1987).
- Rémi Quirion, Robert Chicheportiche, Patricia C. Contreras, Kenneth M. Johnson, David Lodge, S. William Tam, James H. Woods and Stephen R. Zukin, Classification and nomenclature of phencyclidine and sigma receptor sites, Trends in Neurosciences, 10, 11, (444), (1987).
- John Olney, Madelon Price, K.Shahid Salles, Joann Labruyere and Gregory Frierdich, MK-801 powerfully protects against N-methyl aspartate neurotoxicity, European Journal of Pharmacology, 141, 3, (357), (1987).
- Wang Zhi-Xian, Alien F. Ryan and Nigel K. Woolf, Pentobarbital and ketamine alter the pattern of 2-deoxyglucose uptake in the central auditory system of the gerbil, Hearing Research, 27, 2, (145), (1987).
- B.S. Meldrum and R.W. Kerwin, Glutamate receptors and schizophrenia, Journal of Psychopharmacology, 1, 4, (217), (1987).
- Joseph B. Monahan and Jacquelyn Michel, Identification and Characterization of an N‐Methyl‐D‐Aspartate‐Specific L‐[3H]Glutamate Recognition Site in Synaptic Plasma Membranes, Journal of Neurochemistry, 48, 6, (1699-1708), (2006).
- C. A. Tamminga, K. Tanimoto, S. Kuo, T. N. Chase, P. C. Contreras, K. C. Rice, A. E. Jackson and T. L. O'Donohue, PCP‐induced alterations in cerebral glucose utilization in rat brain: Blockade by metaphit, a PCP‐receptor‐acylating agent, Synapse, 1, 5, (497-504), (2004).
- Rachel Haring, Yoel Kloog, Na-ava harshak-Felixbrodt and Mordechai Sokolovsky, Multiple mode of binding of phencyclidines: High affinity association between phencyclidine receptors in rat brain and a monovalent ion-sensitive polypeptide, Biochemical and Biophysical Research Communications, 142, 2, (501), (1987).
- , COMMUNICATIONS, British Journal of Pharmacology, 89, S1, (471P-570P), (2012).
- John Weiss, Mark P. Goldberg and Dennis W. Choi, Ketamine protects cultured neocortical neurons from hypoxic injury, Brain Research, 380, 1, (186), (1986).
- Jacques Vignon, Alain Privat, Isabelle Chaudieu, Alain Thierry, Jean-marc Kamenka and Robert Chicheportiche, [3H]Thienyl-phencyclidine ([3H]TCP) binds to two different sites in rat brain. Localization by autoradiographic and biochemical techniques, Brain Research, 378, 1, (133), (1986).
- Robert J. Brady and John W. Swann, Ketamine selectively suppresses synchronized afterdischarges in immature hippocampus, Neuroscience Letters, 69, 2, (143), (1986).
- Z. Miljkovic and J.F. MacDonald, Voltage-dependent block of excitatory amino acid currents by pentobarbital, Brain Research, 376, 2, (396), (1986).
- S.N. Davies, J. Church, J. Blake, D. Lodge, R.A. Lessor, K.C. Rice and A.E. Jacobson, Is Metaphit a phencyclidine antagonist? Studies with ketamine, phencyclidine and N-methylaspartate, Life Sciences, 38, 26, (2441), (1986).
- A.M. Thomson, Comparison of responses to transmitter candidates at an N-methylaspartate receptor mediated synapse, in slices of rat cerebral cortex, Neuroscience, 17, 1, (37), (1986).
- John W. Olney, Madelon T. Price, Terry A. Fuller, Joann Labruyere, Lisa Samson, Michael Carpenter and Kathryn Mahan, The anti-excitotoxic effects of certain anesthetics, analgesics and sedative-hypnotics, Neuroscience Letters, 68, 1, (29), (1986).
- M.G. Lacey and G. Henderson, Actions of phencyclidine on rat locus coeruleus neurones in vitro, Neuroscience, 17, 2, (485), (1986).
- Linda M. Aanonsen and George L. Wilcox, Phencyclidine selectively blocks a spinal action of N-methyl-d-aspartate in mice, Neuroscience Letters, 67, 2, (191), (1986).
- Andrew L. Gundlach, Brian L. Largent and Solomon H. Snyder, Phencyclidine (PCP) receptors: autoradiographic localization in brain with the selective ligand, [3H]TCP, Brain Research, 386, 1-2, (266), (1986).
- T. Okuda, Comparison of direct and indirect depressant actions of ketamine on dorsal horn cells in rabbits, Neuropharmacology, 25, 4, (433), (1986).
- Wouter Koek, James H. Woods and Paul Ornstein, Phencyclidine-like behavioral effects in pigeons induced by systemic administration of the excitatory amino acid antagonist, 2-amino-5-phosphonovalerate, Life Sciences, 39, 11, (973), (1986).
- , POSTER COMMUNICATIONS, British Journal of Pharmacology, 87, S1, (95P-224P), (2012).
- , POSTER COMMUNICATIONS, British Journal of Pharmacology, 88, S1, (323P-469P), (2012).
- Wouter Koek, Eduardo Kleer, Pamela J. Mudar and James H. Woods, Phencyclidine-like catalepsy induced by the excitatory amino acid antagonist DL-2-amino-5-phosphonovalerate, Behavioural Brain Research, 19, 3, (257), (1986).
- Pat Loo, Albert Braunwalder, John Lehmann and Michael Williams, Radioligand binding to central phencyclidine recognition sites is dependent on excitatory amino acid receptor agonists, European Journal of Pharmacology, 123, 3, (467), (1986).
- J.C. Blake, S.N. Davies, J. Church, D. Martin and D. Lodge, 2-methyl-3,3-diphenyl-3-propanolamine (2-MDP) selectively antagonises N-methyl-aspartate (NMA), Pharmacology Biochemistry and Behavior, 24, 1, (23), (1986).
- Yoshimi Ikemoto, Ketamine depression of excitatory and inhibitory cholinergic responses in Aplysia neurons, European Journal of Pharmacology, 132, 1, (97), (1986).
- T. E. Salt, Mediation of thalamic sensory input by both NMDA receptors and non-NMDA receptors, Nature, 322, 6076, (263), (1986).
- A.M. Thomson and D.C. West, N-methylaspartate receptors mediate epileptiform activity evoked in some, but not all, conditions in rat neocortical slices, Neuroscience, 19, 4, (1161), (1986).
- David T. Manallack, Philip M. Beart and Andrew L. Gundlach, Psychotomimetic σ-opiates and PCP, Trends in Pharmacological Sciences, 7, (448), (1986).
- Peter W. Gage and Brian Robertson, Prolongation of inhibitory postsynaptic currents by pentobarbitone, halothane and ketamine in CA1 pyramidal cells in rat hippocampus, British Journal of Pharmacology, 85, 3, (675-681), (2012).
- D. Lodge and G.A.R. Johnston, Effect of ketamine on amino acid-evoked release of acetylcholine from rat cerebral cortex in vitro, Neuroscience Letters, 56, 3, (371), (1985).
- C.E. Herron, R.A.J. Lester, E.J. Coan and G.L. Collingridge, Intracellular demonstration of an N-methyl-d-aspartate receptor mediated component of synaptic transmission in the rat hippocampus, Neuroscience Letters, 60, 1, (19), (1985).
- D. Martin and D. Lodge, Ketamine acts as a non-competitive N-methyl-d-aspartate antagonist on frog spinal cord in vitro, Neuropharmacology, 24, 10, (999), (1985).
- Alex M. Thomson, David C. West and David Lodge, An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine?, Nature, 313, 6002, (479), (1985).
- C.R. Honey, Z. Miljkovic and J.F. Macdonald, Ketamine and phencyclidine cause a voltage-dependent block of responses to l-aspartic acid, Neuroscience Letters, 61, 1-2, (135), (1985).
- DAVID LODGE, Species variation in sensitivity of general anaesthesia to high pressure, Nature, 314, 6009, (386), (1985).
- Carmencita Pilapil, Patricia Contreras, Thomas L. O'Donohue and Remi Quirion, Autoradiographic distribution of [3H]dexoxadrol (a phencyclidine-related ligand) binding sites in rat and human brain, Neuroscience Letters, 56, 1, (1), (1985).
- Neil L. Harrison and Michael A. Simmonds, Quantitative studies on some antagonists of N‐methyl D‐aspartate in slices of rat cerebral cortex, British Journal of Pharmacology, 84, 2, (381-391), (2012).
- M.R. Duchen, N.R. Burton and T.J. Biscoe, An intracellular study of the interactions of N-methyl-dl-aspartate with ketamine in the mouse hippocampal slice, Brain Research, 342, 1, (149), (1985).
- John Church, David Lodge and Stephen C. Berry, Differential effects of dextrorphan and levorphanol on the excitation of rat spinal neurons by amino acids, European Journal of Pharmacology, 111, 2, (185), (1985).
- A.M. Thomson and D. Lodge, Selective blockade of an excitatory synapse in rat cerebral cortex by the sigma opiate cyclazocine: An intracellular, in vitro study, Neuroscience Letters, 54, 1, (21), (1985).
- Stephen C. Berry, Nabil A. Anis and David Lodge, The effect of the dioxolanes on amino acid induced excitation in the mammalian spinal cord, Brain Research, 307, 1-2, (85), (1984).
- , COMMUNICATIONS, British Journal of Pharmacology, 81, S1, (1P-194P), (2012).
- Stephen C. Berry and David Lodge, Benz(F)isoquinolines as excitatory amino acid antagonists: An indication of their mechanism of action?, Biochemical Pharmacology, 33, 23, (3829), (1984).
- Hilary J. Little and H. David Atkinson, Ketamine potentiates the responses of the rat superior cervical ganglion to GABA, European Journal of Pharmacology, 98, 1, (53), (1984).
- Remi Quirion, Debora A. DiMaggio, Edward D. French, Patricia C. Contreras, Joseph Shiloach, Candace B. Pert, Hilleary Everist, Agu Pert and Thomas L. O'Donohue, Evidence for an endogenous peptide ligand for the phencyclidine receptor, Peptides, 5, 5, (967), (1984).
- Neil L. Harrison and Michael A. Simmonds, Modulation of the GABA receptor complex by a steroid anaesthetic, Brain Research, 323, 2, (287), (1984).
- D. Lodge, S.C. Berry, J. Church, D. Martin, A. McGhee, H-M. Lai and A.M. Thomson, Isomers of cyclazocine as excitatory amino acid antagonists, Neuropeptides, 5, 1-3, (245), (1984).
- S.C. Berry, S.L. Dawkins and D. Lodge, Comparison of s‐ and κ‐ opiate receptor ligands as excitatory amino acid antagonists, British Journal of Pharmacology, 83, 1, (179-185), (2012).
- D. Lodge, CENTRAL ACTIONS OF KETAMINE AND RELATED PSYCHOTOMIMETIC BENZOMORPHANS, Veterinary Anaesthesia and Analgesia, 12, 1, (61-67), (2008).
- K.D. Cullen and R.J. Martin, Effects of injectable anaesthetics on responses to L‐glutamate and on spontaneous synaptic activity in lamprey reticulo‐spinal neurones, British Journal of Pharmacology, 82, 3, (659-666), (2012).
- Stephen C. Berry, Norman R. Burton, Nabil A. Anis and Davis Lodge, Stereoselective effects of two phencyclidine derivatives on N-methylaspartate excitation of spinal neurones in the cat and rat, European Journal of Pharmacology, 96, 3-4, (261), (1983).
- Linda Li and Phillip E. Vlisides, Ketamine: 50 Years of Modulating the Mind, Frontiers in Human Neuroscience, 10.3389/fnhum.2016.00612, 10, (2016).
- Charles F. Zorumski, Peter Nagele, Steven Mennerick and Charles R. Conway, Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy, Frontiers in Psychiatry, 10.3389/fpsyt.2015.00172, 6, (2015).
- Vinita Jagannath, Zacharias Faidon Brotzakis, Michele Parrinello, Susanne Walitza and Edna Grünblatt, Controversial Effects of D-Amino Acid Oxidase Activator (DAOA)/G72 on D-Amino Acid Oxidase (DAO) Activity in Human Neuronal, Astrocyte and Kidney Cell Lines: The N-methyl D-aspartate (NMDA) Receptor Hypofunction Point of View, Frontiers in Molecular Neuroscience, 10.3389/fnmol.2017.00342, 10, (2017).
- Inseyah Bagasrawala, Nada Zecevic and Nevena V. Radonjić, N-Methyl D-Aspartate Receptor Antagonist Kynurenic Acid Affects Human Cortical Development, Frontiers in Neuroscience, 10.3389/fnins.2016.00435, 10, (2016).
- Julian Cheron and Guy Cheron, Beta‐gamma burst stimulations of the inferior olive induce high‐frequency oscillations in the deep cerebellar nuclei, European Journal of Neuroscience, , (2018).
